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RESPONSES TO DNA DAMAGE 
 
Guoming Sun, Ph.D. 
University of Pittsburgh, 2009
           
  Genome stability is essential for cells to survive. Consequently, cells have evolved 
intricate responses that include transcriptional changes, cell-cycle arrest, activation of DNA 
repair, and apoptosis.  Such responses prevent permanent fixation of DNA damage induced by 
genotoxic agents into the genome, thus contributing to genome stability.  
A collection of proteins implicated in DNA damage responses are called Inhibition of 
Growth (ING) family, which are a group of small molecular weight proteins that regulate a 
variety of biological functions ranging from senescence, cell cycle arrest, apoptosis and DNA 
repair. ING proteins interact with Histone Acetyl-transferases (HAT) and Histone Deacetylases 
(HDAC) to alter the state of chromatin compaction and acetylation status of many proteins 
during DNA damage. A specific member of the ING family, ING2 has been implicated in 
modulating the tumor suppressor, p53 function through p300 HAT-mediated acetylation. 
Irradiation fails to upregulate ING2, but increases its association with transcription co-activator 
p300. That p300 HAT activation in the cells with ING2 knock down is hampered post-irradiation 
suggests that the interaction between ING2 and p300 is indispensable for the upregulation of the 
p300 HAT activity. Cells deficient in protein kinase Ataxia Telangiectasia Mutated (ATM) 
displays impaired p300 HAT activation and less association between p300 and ING2 following 
ionizing radiation, indicating that ATM function is also required.  
Alkylating agent, N-methyl-N’-nitro-N-nitrosoguanidine (MNNG) upregulates ING2 
level in both time- and dose-dependent manner. We further observed that ING2 regulates the cell 
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death response induced by this alkylator through a mechanism involving acetylation and 
stabilization of p73. Induction/acetylation of p53, in response to MNNG, however, proceeds in 
an ING2-independent manner. Inhibition of c-Abl by STI571 treatment blocked ING2 
upregulation and p73 acetylation induced by MNNG. Similarly, MLH1- suppressed or mutated 
cells displayed defective ING2 upregulation and p73 acetylation in response to MNNG, which 
suggests that Mlh1- and c-Abl-dependent upregulation of ING2 activates the cell death response 
to MNNG through p73 acetylation. 
Taken together, these findings demonstrate that ING2 plays an important role in the 
cellular responses to different DNA damage by regulating the acetylation of tumor suppressors. 
 v 
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1.0  INTRODUCTION 
1.1 DNA DAMAGE 
Mutation in DNA occurs at a rate of 1,000 to 1,000,000 lesions per cell per day. Failure 
to repair the damaged DNA will result in mutations in the genome, thus loss of the integrity of 
the genetic information. The correctness of the genetic information is vital to keep the cells from 
malignancy or death (Browner et al., 2004). To prevent permanent fixation of mutations, 
eukaryotic cells activate a complex signaling network that functions to mediate DNA repair and 
activate cell-cycle checkpoints. Persistent DNA damage activates cell death responses.  
DNA damage can be classified into endogenous and exogenous damage. The endogenous 
damage can be induced by the normal metabolic byproducts, such as Reactive Oxygen Species 
(ROS) (Stadtman, 1992), and errors that occur during replication. Endogenous damage can 
further be subdivided into four major types according the modification inflicted on the DNA: 
oxidation, alkylation, hydrolysis and mismatch.  
The exogenous DNA damage can be inflicted by multiple types of agents. For example, 
pyrimidine dimers introduced by UV, induces the cross linking between neighboring cytosine 
and thymine bases. Double Strand Breaks (DSBs) and Single Strand Breaks (SSDs) can be 
created by the ionizing radiation (IR) or high temperature, which are lethal to the cell. DNA 
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adducts can also be caused by mutagens such as polycyclic hydrocarbon or hydrogen peroxide 
(H2O2) originating from pollutants (Cadet et al., 2008).     
In general, damage such as thymine dimer induced by UV and methylation of DNA base 
introduced by chemicals can be corrected by direct reversal. In most cases, cells use the other 
strand as a template to correct the defect. Briefly, cells excise the defected strand, remove the 
impaired nucleotide and synthesize a new nucleotide to replace the defected one with the 
guidance of undamaged strand (Lindahl and Wood, 1999). Base Excision Repair (BER), 
Nucleotide Excision Repair (NER), and Mismatch Repair (MMR) are the three major excision 
repair mechanisms. To repair the especially hazardous double strand breaks, cells have evolved 
two mechanisms with different repair strategies, Non-Homologous End Joining (NHEJ) and 
Homologous Recombination (HR) (Moore and Haber, 1996). In NHEJ, two ends are joined 
directly by the DNA ligase IV without template guidance. NHEJ is a low-fidelity repair 
mechanism because of mutation, deletion or translocation incurred during the repair process 
(Budman and Chu, 2005). On the other hand, HR uses a sister chromatid or homologous 
chromosome as template to repair the break thus achieving high fidelity (Jung and Alt, 2004).       
1.2 ING FAMILY AND ACETYLATION 
Inhibitor of Growth (ING) family of proteins are a group of tumor suppressors that 
control cell growth/proliferation, and cancer (Campos et al., 2004). All of the family members 
share a highly conserved Plant Homeodomain (PHD) near the C-terminal end and a nuclear 
localization sequence (NLS), as shown in Figure 1 (Gong et al., 2005). The highly conserved 
structure of ING family suggests that they have similar functions in cells. 
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In S. cerevisiae, three ING proteins, namely Pho23, Yng1, and Yng2, co-purified as 
stable components of the Sin3/Rpd3 HDAC, NuA3, and NuA4 HAT complexes, respectively 
(Howe et al., 2002; Nourani et al., 2001; Nourani et al., 2003). In higher organisms, ING1 is 
observed to reside within the mSin3A-HDAC complex (Kuzmichev et al., 2002) and can also 
associate with the p300 HAT (Vieyra et al., 2002).  Similarly, ING3 is documented to form a 
stable complex with Tip60/NuA4 HAT (Doyon et al., 2004).  ING4 and ING5 have been found 
to associate with HBO1 HAT complex (Doyon et al., 2006). Biochemical analysis showed that 
ING4 is essential for bulk histone H4 acetylation. All members of the ING family harbor a 
highly conserved Plant Homeodomain (PHD) that is commonly found in various chromatin 
remodeling proteins (Aasland et al., 1995). The PHD of ING2 regulates p53-dependent apoptosis 
through phosphoinositides signaling (Gozani et al., 2003). Genetic and crystal structure analyses 
revealed that ING proteins bind to trimethylated lysine of histone H3 in yeast and mammalian 
cells via the PHD finger (Martin et al., 2006; Pena et al., 2006; Shi et al., 2006). There is some 
evidence that ING proteins may bind directly to DNA (Kataoka et al., 2003). Deletion leucine 
zipper (LZL) domain in ING2 abrogated its association with p53, but not with p300. 
Conceivably, ING2 modulates p53-dependent chromatin remodeling, apoptosis and DNA repair 
by functioning as a scaffold protein to mediate the interaction between p53 and p300 (Wang et 
al., 2006a; Wang et al., 2006b). 
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Figure 1: Structure of ING family proteins 
              Plant Homeodomain  
 Nuclear Localization Sequence 
  Leucine Zipper Domain 
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2.0  ATM UPREGULATES P300 HAT ACTIVITY AFTER IRRADIATION 
THROUGH ING2  
 5 
 2.1 INTRODUCTION 
2.1.1 Ataxia-Telangiectasia Mutated (ATM) and Double Stand Break (DSB) 
DNA repair mechanisms are vital to the survival and normal functioning of the cells. 
Mutations or deletions in the regions encoding proteins composing these DNA repair 
machineries impair the mechanisms and result in loss of genome integrity. The failure of a 
mechanism to repair damaged DNA may lead cells to neoplasia and dysfunction. Several 
diseases linked to genetic defect disrupting these mechanisms are characterized by tissue 
degeneration (especially central nervous system and immune system), sensitivity to DNA 
damaging agents and high predisposition to cancer (Vessey et al., 1999). One of these 
syndromes, Ataxia Telangiectasia (A-T), is a recessive autosomal human disorder. A-T patients 
show ocular telangiectasia, progressive neuronal degeneration, immune deficiency, extreme 
sensitivity to ionizing radiation, premature aging and high predisposition to cancer Cells 
obtained from A-T patients display radiosensitivity, undergo premature senescence, and display 
faulty cell cycle checkpoint activation in response to irradiation (Beamish and Lavin, 1994; 
Chehab et al., 2000; Falck et al., 2002; Lavin and Shiloh, 1997; Lim et al., 2000; Peng et al., 
1997; Xu et al., 2002). After decades of research, a gene was found to be mutated in A-T patients 
and the gene product was responsible for the syndromes that A-T patients exhibited, so this gene 
was called Ataxia Telangiectasia Mutated (ATM) (Savitsky et al., 1995).     
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Compared to other types of DNA lesions, DSBs are highly cytotoxic. In response to 
DSBs, cells execute cell-cycle arrest, in addition to activating DNA repair. When the lesions are 
too overwhelming to repair, apoptosis will be activated (van Gent et al., 2001). A complicated 
network in the cell mediates all these activities, and ATM plays the most crucial role in it. A tri-
meric protein complex, Mre11-Rad50-Nbs1 (MRN) is shown to act as a DSBs sensor and recruit 
ATM to the breakage sites, although the exact mechanism of how the DNA damage signal is 
conveyed to ATM has yet to be elucidated (Lee and Paull, 2004; Lee and Paull, 2005). DSB is 
shown to induce intermolecular auto-phosphorylation of ATM kinase at serine 1981, which 
dissociates the inactive dimer of ATM and initiates kinase activity of ATM (Bakkenist and 
Kastan, 2003). DSB-activated ATM kinase phosphorylates numerous substrates including p53, 
c-Abl, BRAC1 to regulate cellular responses. All ATM substrates contains a general consensus 
motif – serine or threonine that is followed by a glutamine (SQ/TQ motif) (Kim et al., 1999b). 
Until now, there have been more than a dozen substrates of ATM found in vivo, and this list 
keeps increasing with further investigation of ATM. Among them, p53 is the best studied 
substrate of ATM, as well as c-Abl (Baskaran et al., 1997; Shangary et al., 2000).  
Following IR-induced activation, ATM directly phosphorylates p53 on serine 15 leading 
to stabilization.  ATM activates  protein kinase, Chk2 by phosphorylation on threonine 68, which 
in turn phosphorylates p53 on serine 20 (Banin et al., 1998; Matsuoka et al., 2000). These dual 
phosphorylations prevent p53 from degradation by inhibiting ubiquitination of p53 executed by 
ubiquitin ligase MDM2 (Shieh et al., 1997; Unger et al., 1999). This stabilization is crucial to 
p53’s function as a tumor suppressor and transcription factor. Consequently, lack of ATM-
mediated p53 phosphorylation is responsible for the blunted up-regulation of p21WAF-1/CIP-1 and 
defective G1/S cell arrest observed in irradiated A-T cells (Di Leonardo et al., 1994; el-Deiry et 
 7 
al., 1993). In addition, ATM regulates p53 levels by phosphorylating MDM2, weakening 
MDM2-p53 interaction and promoting p53 induction (Maya et al., 2001).  Furthermore, ATM-
dependent phosphorylation of p53 on residues serine 46 and serine 9 are documented to be 
important for p53-mediated apoptotic response to radiation treatment (Saito et al., 2002). 
In summary, ATM regulates an intricate network in response to DNA damage through 
phosphorylation and activation of multiple substrates. Further understanding of ATM and its 
substrates is anticipated to broaden our knowledge of cancer initiated by unrepaired DNA 
damage and provide novel targets for pharmaceutical therapy. 
 
2.1.2 p53 acetylation 
 Acetylation is another post-translational modification that controls p53 activity in 
response to genotoxic stress (Sakaguchi et al., 1998). Gu et al. reported that p53 is acetylated at 
multiple lysine residues (K373/K382) on its carboxyl-terminal regulatory domain, and that this 
acetylation stimulates the sequence-specific DNA-binding activity of p53 (Gu and Roeder, 
1997). Subsequent studies showed that, in vivo, p53 can be acetylated on both on N-terminal and 
C-terminal domains in response to a variety of cellular stress signals including IR, UV, 
hydroxyurea and hypoxia (Gottifredi et al., 2001; Gu and Roeder, 1997; Ito et al., 2001; Liu et 
al., 1999; Sakaguchi et al., 1998).  
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2.1.3 Acetyltransferase 
The principal enzymes implicated in p53 acetylation are the transcriptional co-activator 
p300 and its close family member CREB Binding Protein (CBP). p300 and CBP are distinct, but 
related, proteins that participate in a wide variety of cellular process, including proliferation, 
differentiation and apoptosis (Avantaggiati et al., 1997; Puri et al., 1997; Yuan et al., 1996). 
Owing to their intrinsic acetyl-transferase activity, p300 and CBP facilitate chromatin remolding 
through histone acetylation (Bannister and Kouzarides, 1996). Thus, this post-translational 
modification has emerged as a key mechanism in regulating gene expression (Ogryzko et al., 
1996). Mice deficient in either p300, CBP or both display embryonic lethality while 
heterozygotes exhibit defects in growth and development (Yao et al., 1998), indicating a role for 
p300/CBP in embryonic development. Cells deficient in p300 display radiosensitivity and 
impaired apoptotic response to IR exposure implying a critical function for this molecule in 
DNA damage response (Yuan et al., 1999). In humans, deregulation of p300 and CBP activities 
are reported to cause some specific types of leukemia (Gayther et al., 2000). Additionally, 
patients with Rubinstein-Tayabi syndrome exhibiting developmental abnormality and skeletal 
deformity are heterozygous for mutation in the CBP allele (Petrij et al., 1995). CBP 
heterozygous mice also show skeletal abnormalities reminiscent of Rubinstein-Tayabi syndrome 
(Tanaka et al., 1997).  
2.1.4 Summary 
Both p300 and ATM-deficient cells are sensitive to radioactivity (Lavin and Khanna, 
1999; Pacini et al., 1999). This prompted us to investigate a potential role for ATM in 
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controlling p300 function in response to IR. As outlined in this study, we show that Histone 
Acetyl-Transferase (HAT) activity of p300 is elevated in response to IR in an ATM-dependent 
manner. In agreement with this, we observed impaired p53 acetylation in ATM-deficient cells 
after IR. Using both in vivo and in vitro approaches we show that p53 phosphorylation 
kinetically precedes acetylation and that phosphorylation enhances p53 as a substrate for p300 
acetyltransferase. Importantly, we demonstrate that ING2 participates in the acetylation of p53 
and in addition required for activation of p300 HAT activity. Together, the results demonstrate 
ATM as an upstream regulator of p300 HAT activity mediating through ING2 in the IR-induced 
signaling pathway and that p53 is modified by phosphorylation/acetylation in a concerted 
manner. 
2.2 MATERIALS AND METHODS 
2.2.1 Cell Culture 
Normal (GM00730) and A-T (GM02530) human fibroblasts were obtained from Coriell 
Institute for Medical Research (Camden, NJ) and Cultured in DMEM supplemented with 10% 
fetal bovine serum (FBS), 5% essential amino acids, 2% non-essential amino acids, vitamins, 
100 units/ml pen/strep and 5 mM L-gultamine. Normal (GM0536B) and A-T (GMO1525E) 
lymphoblastoid cell lines were obtained from NIGMS Human Genetic Mutant Cell Repository 
(Camden, NJ) and cultured in RPMI-1640 supplemented with 15% heat inactivated FBS, 100 
units/ ml pen/strep and 5mM L-Glutamine (Ziv et al., 1997). SV-40 transformed A-T fibroblast 
cell line AT22IJ-T stably expressing full-length recombinant ATM (designated as YZ-5) or 
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stably transfected with empty vector (designated as EBS-7) were cultured as described by Ziv et 
al (Ziv et al., 1997). The p53 inducible Tet-off cell line LNZ-308 was cultured in DMEM 
supplemented with 10% FBS, 100 unites/ml pen/strep and 5 μg/ml tetracycline as described 
(Gossen and Bujard, 1992). All cell lines were maintained at 37oC in a humidified 5% CO2 
incubator. 
2.2.2 Irradiation 
Exposure of cells to different doses of γ-radiation was performed at room temperature 
using a Gammacell 1000 Irradiator (Atomic Energy of Canada Ltd) equipped with a 137Cs source 
(dose rate = 318 rad/min). After irradiation the media was changed and cells returned to the 
incubator, and harvested at indicated time points. 
2.2.3 Reagents and Antibodies 
Caffeine and wortmannin were purchased from Sigma Chemical Company (St Louis, 
MO). Where indicated, cells were pretreated with 5 mM caffeine or 10 μM wortmannin in 
serum-free media for 1 hour at 37oC before irradiation. Lys-CoA was synthesized according to 
the published method of Lau et al (Lau et al., 2000), purified by HPLC (c-18 colum), and 
analyzed by mass spectroscopy. The inhibitory effects of the purified Lys-CoA were confirmed 
in in vitro acetylation reactions using immunoprecipitated p300 and purified histones as 
substrates. 
The anti-acetylation lysine antibody PAN-193 (ab-193-100) was purchased from Upstate 
Biotechnology (Lake Placid, NY). Polyconal anti-p300 (sc-584), anti-β-tubulin (sc-935) and 
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monoclonal anti-p53 (DO-1, sc-126) antibodies were obtained from Santa Cruz Biotechnology. 
Phospho-specific anti-p53-Ser15 (9284 S) was purchased from Cell Signaling (Beverly, MA). 
ING2 antibody (rat, monoclonal) was a generous gift from Dr. Or Gozani at Stanford University. 
2.2.4 Reversible cell permebilization 
Cells were treated with Lys-CoA as described by Bandhopadhyay et al. (Bandyopadhyay 
et al., 2002). Briefly HEK-293 cells (5x106) were trypsinized and resuspended in 1 ml of ice-
cold buffer (ICB) containing 10 mM HEPES, pH 7.0, 0.14 M KCl, 0.01M NaCl and 2.4 mM 
MgCl2. 50 μl of ICB solution containing 0.5% trypan blue with or without Lys-CoA was added 
to 500 μl of cell suspension containing 50 ul transport reagent (1.2 mg/ml 
sphigosylphosphorycholine) and subsequently incubated at 37oC for 30 minutes. Following this 
100 μl of stop reagent (20% fatty acid-free BSA in ICB) was added and cells seeded in 60 mm 
dishes in 5 ml of complete growth media and placed in a 37oC incubator. Following 12 hr 
incubation, cells were re-fed with fresh media and cultured for 24 to 48 hr prior to IR exposure.  
2.2.5 Immunoblotting 
Cells were harvested by scraping, washed with ice-cold PBS, and lysed in cold 1X lysis 
buffer containing 10 mM Tris HCl pH 8.0, 240 mM NaCl, 5 mM EDTA, 1 mM DTT, 0.1 mM 
PMSF, 1% Triton X-100, 1 mM sodium vanadate, and 1 μg/ml of leupeptin, pepstatin, and 
aprotinin by incubation on ice for 20 min.  Lysates were cleared by centrifugation and protein 
concentration was determined using Bradford dye reagent from BioRad.  For immunoblotting, 
proteins were resolved by SDS-PAGE on 4-12% gradient gels, electro-transferred to Immobilon-
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P (Millipore, Billerica, MA) membranes and probed with indicated primary antibody and 
subsequently with HRP-conjugated secondary antibodies.  The membrane was developed using 
chemiluminescence reagent Luminol.  Where indicated, the membrane was stripped by 
incubation at 40oC for 30 min in 65 mM Tris-HCl pH 6.7, 100 mM β-mercaptoethanol (BME) 
and 2% SDS and then probed with indicated antibody. 
 
2.2.6 Immunoprecipitation 
Immunoprecipitation wias performed as described (Shangary et al., 2000). Briefly, 1x106 
cells were lysed in 500 μl of 1X lysis buffer (20 mM Tris-HCl, pH7.5 / 150 mM NaCl / 5 mM 
EDTA / 0.5% NP40 / 1 mM NaF / 1 mM DTT / 1 mM Na-Vanadate) and clarified by 
centrifugation. Lysates were adjusted for equal protein content and 5μl of antibody (anti-p300 / 
anti-ING2/ anti-ATM) was added, and incubated overnight at 4oC on a rocking platform. 25 μl of 
50/50 (v/v) slurry of protein A-Sepharose beads (American Pharmacia Biotech) in PBS was 
added and incubation continued for another 2 hours. Immune-complexes were collected by quick 
spin, washed three times in 1x lysis buffer containing 500 mM NaCl, once with 1X lysis buffer, 
and subsequently used in HAT assays or analyzed by SDS-PAGE and immunoblotting.  
2.2.7 Histone Acetyltransferase (HAT) Assay 
HAT assays were performed as described by Zeng et al (Zeng et al., 2000). p300 
immune-complexes were washed once in HAT buffer (50 mM Tris-HCl, pH 8.0 / 10% glycerol 
(v/v) / 1 mM DTT / 0.1 mM EDTA / 10mM sodium butyrate / protease inhibitors) and 
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resuspended in 20 μl of HAT buffer. 5 μg of calf thymus histones (Boehringer Mennheim), 1 μM 
acetyl CoA and 50 Ci of 14C-Acetyl CoA (ICN, 55mCi/mM) were added, and the reaction 
mixture was incubated for 45 min at room temperature. The reaction was terminated by addition 
of 25 μl SDS-sample loading buffer and immersion in a boiling water bath.  The proteins were 
resolved by 4-12% SDS-PAGE, electrotransferred onto Immobilon-P membrane.  Radiolabeled 
substrates were visualized by autoradiography. Enzyme abundance in each reaction was 
confirmed by immunoblotting with anti-p300 antibody 
2.2.8 In vitro ATM Kinase Assay 
ATM kinase assay were carried out as described (Shangary et al., 2000).  Mock (DMSO) 
and IR-treated cells or control cells were harvested 1 hour post-irradiation. Lysates were 
prepared as described and normalized for equal protein content. Lysates were 
immunoprecipitated by incubating with 5 μl of anti-ATM antibody for 2 hours on a roto-mixer at 
4oC. 25 μl of 50/50 (v/V) slurry of protein A-sepharose beads in PBS were added and incubation 
continued for 2 hours at 4oC. The beads were collected by quick spin, washed twice with lysis 
buffer and once with 100 mM NaCl supplemented with protease inhibitors. The beads were 
resuspended in 25 μl of kinase buffer (25 mM HEPES, pH 7.5, 50 mM KCl, 0.5 mM EDTA, 5 
mM DTT, and 0.5 mM phenylmethylsulfonyfluoride). The beads were incubated wuth 1 μg of 
purified recombinant GST-p53, 5 mM cold ATP and 30mCi of [γ-32 P] ATP (5000 mCi/mM 
ICN) and incubated at 30oC for 30minutes. The reaction was terminated by addition of 25 μl of 
SDS-sample loading buffer and boiling for 10 minutes. The reaction products were resolved on 
10% SDS-PAGE, electrotransferred on Immobilon-P (Milipore) membranes and analyzed by 
autoradiography.  
 14 
2.2.9 RNA interference 
Overlapping synthetic oligonucleotides corresponding to sequences specific for the 
human ING2 (5’– AGAGAGCACTAATTAATAG -3’) transcripts were hybridized and cloned 
into pSIREN-RETRO-Q (Clontech, La Jolla, CA).  The recombinant pSiren plasmid was co-
transfected with pCL-ampho plasmid encoding the packaging viral DNA into the packaging cell 
line, 293T (Clontech) using Lipofectamine 2000 (Invitrogen, Carlsbad, CA).  The supernatant 
containing the viral DNA was collected, filtered and used to infect HCT-116 cells with 
polybrene-supplemented medium.  Cells were selected by incubation with puromycin (1 μg/ml) 
for 4 days and downregulation of target gene expression was confirmed by immunoblotting. 
2.2.10 Microscopy  
Cells were grown on pre-sterilized glass cover slips and either mock- treated or exposed 
to IR (5 Gy). Cells were then washed 3x with Hank's Balanced Salt Solution (HBSS) containing 
10 mM Hepes, 2 mM CaCl2, and 4 mg/ml BSA.  Cells were fixed in 4% paraformaldehyde in 
HBBS for 5 min and then permeabilized in 100% methanol for 5 min.  Cells were then stained 
with ING2 antibody (rabbit) for 1 hr at 37oC.  The cells were subsequently stained with Alexa 
Fluor 555 goat anti-rabbit IgG-conjugated secondary antibody (Invitrogen, Carlsbad, CA). DNA 
was counterstained with DAPI.  Photomicrographs were recorded using a Nikon fluorescence 
microscope (TE S2000) equipped with CCD camera. 
 15 
2.3 RESULTS 
2.3.1 IR induces p300 histone acetyltransferase activity. 
Genotoxic agents such as ionizing and ultraviolet radiation induce acetylation of a 
number of proteins including p53, p73 and E2F-1, mediated by HAT activity of p300/CBP 
(Gottifredi et al., 2001; Gu and Roeder, 1997; Ito et al., 2001; Liu et al., 1999; Sakaguchi et al., 
1998). To identify the mechanism leading to increased acetylation of proteins after DNA 
damage, we monitored alterations in p300 HAT activity. Logarithmically grown HEK-293 cells 
were exposed to 5 Gy (500 rad) of IR and p300 Histone Acetyltransferase (HAT) activity was 
determined by immunoprecipitation followed by incubation of IP-complex with histones and 14C 
acetyl CoA in an in vitro HAT assay.  Stringent conditions were used for immunoprecipitation so 
that no other HAT proteins such as PCAF could be co-precipitated with p300. As shown in 
Figure 1A, p300 immunoprecipitated from IR-exposed cells displayed increased HAT activity as 
demonstrated by increased incorporation of 14C onto histones. Untreated cells showed only a 
basal level of HAT activity. The presence of comparable levels of p300 protein in control and 
IR-treated cells (Figure 2A bottom panel) showed that the acetyl transferase activity is in fact 
stimulated during DNA damage. Quantitation of 14C incorporation onto histones revealed ~3.5, 
5, 6.1 and 5.8 fold increase in p300 HAT activity at 1, 2, 4 and 8 h post-IR respectively.  
Activation was dose-dependent: increasing doses of IR exposure led to higher HAT activities 
(Figure 2B). In contrast to mock-treated, IR-exposed cells showed 3.5, 3.6, 3.7 and 6.1 fold 
increases in p300 HAT activities in response to 5, 10, 15 and 20 Gy of IR, respectively. 
Together, these results showed that p300 HAT activation proceeds in both time- and dose-
dependent manner. 
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Figure 2: Time and dose-dependent activation of p300 HAT activity by IR. 
(A) HEK-293 cells were irradiated with 5 Gy of IR, and harvested 0, 1, 2, 4, and 8 h 
later. Lysates were formed, adjusted for equal protein content. Subsequently, p300 was 
immunoprecipitated from these lysates and HAT activity was measured by incubating 
immunoprecipitated-p300 with histones in presence of [14C] acetyl-CoA. The reaction 
products were resolved by 12% SDS-PAGE, transferred onto Immobilon-P. The radio-
labeled bands were detected by autoradiography. The top portion of the membrane was 
probed with anti-p300 antibody to assure equivalent acetyltransferase abundance. (B) 
HEK-293 cells were exposed to 5, 10, 15 and 20 Gy of IR and lysates were formed 1 h 
after irradiation. p300 was immunoprecipitated from these lysates, and HAT activity 
was assessed as described in panel A. p300 abundance was determined by 
immunoblotting. 
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Figure 3: Time and dose-dependent p300 HAT activation in HEK-293, HeLa and 
MCF-7 cells following IR exposure. 
(A) HEK-293, HeLa and MCF-7 cells were exposed to 5 Gy of IR and HAT activity 
was assessed as described in Figure 2. (B) HEK-293, HeLa and MCF-7 cells were 
exposed to 5, 10, 15, 20 Gy of IR and HAT activity was measured 1 hr after. Fold 
activation was determined by densitometric scanning of the labeled histone bands using 
a phosphor-imaginer analysis. 
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2.3.2 IR-induced p300 HAT activation is not cell-line specific. 
To determine whether p300 activation induced by IR proceeds in a non cell-type specific 
manner, we conducted parallel HAT assays in HeLa and MCF-7 cells.  Similar to the results 
attained in HEK-293 cells, activation in response to IR exposure occured in both cells.  
Importantly, both the cells showed time and dose-dependent activation of p300 HAT activity in 
response to IR exposure (Figure 3). 
2.3.3 ATM is required for IR-induced p300 HAT activity upregulation. 
ATM and ATR kinases critically modulate cellular responses to DNA damage through 
phosphorylation and activation of a number of downstream molecules. To evaluate their 
involvement in p300 HAT activation, we tested the effect of caffeine, an ATM/ATR kinase 
inhibitor on IR-induced p300 HAT activation. HEK-293 cells were exposed to IR in the presence 
of caffeine and p300 HAT activation was assessed by HAT assay. As shown in Figure 4, caffeine 
treatment blocked p300 HAT activation. Whereas cells exposed to IR showed ~3.5 fold increase 
in p300 HAT activity, caffeine-treated cells showed ~1.5 fold increase in p300 HAT activity 
(Figure 4, compare lane 2 to 4). We next examined if ATM function is specifically required for 
p300 HAT activation by IR. We compared HAT activation in normal (GM 00730) and A-T 
fibroblasts (GM 02530, ATM-deficient). Compared to normal fibroblasts cells which displayed 
6.5 fold p300 HAT activation, A-T fibroblasts showed no increase in HAT activation by IR 
(Figure 5A, top panel).  Anti-p300 immunoblotting of the lysates obtained from these cells 
showed p300 levels comparable to normal cells (bottom panel). In a parallel experiment, HAT 
activity in normal (GM0536B) and A-T lymphoblastoid cells (GM01525E) was also examined. 
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Similar to the results observed in fibroblast cells, p300 HAT activity displayed a clear increase 
after IR in normal lymphoblasts while no p300 HAT activation was seen in A-T deficient 
lymphoblastoid cells (Figure 5B). To confirm the ATM requirement, we examined p300 HAT 
activation in SV-40 transformed AT-fibroblasts expressing recombinant human ATM 
(designated YZ-5) and cell line stably transfected with empty vector (designated EBS-7). 
Indicating a requirement for ATM function, p300 obtained HAT activity in EBS-7 showed no 
HAT activation whereas ATM reconstituted YZ-5 cells exhibited ~3.9 fold increase in HAT 
activity (Figure 5C). Taken together, these results indicate a requirement for ATM function in 
p300 HAT activation induced by IR.  
 
Figure 4: p300 HAT  activation  in th e pres ence or absence of caffeine post-IR   
HEK-293 cells were either untreated or pretreated with 5 mM caffeine and exposed to 5 
Gy of irradiation. One hour after IR, the cells were harvested and HAT activity and 
p300 abundance were measured. 
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 Figure 5: IR-induced p300 HAT activation requires ATM. 
(A) Normal (GM00730) and ATM deficient fibroblasts (GM02530) were either exposed 
to 5 Gy of IR or were unexposed and p300 HAT activity and p300 abundance measured 
1 hr after IR. (B) Normal (GM0536B) and ATM deficient lymphoblastoid (GM01525E) 
cells were analyzed for irradiation-induced (5 Gy, 1 hr after IR) activation of p300 HAT 
activity. (C) p300 HAT activity was measured in the SV-40 transformed isogenic 
fibroblast lines ATM-proficient YZ-5 and ATM-deficient EBS-7 1 hr after exposure to 
5 Gy of irradiation. 
. 
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2.3.4 Acetylation of p53 after IR is an ATM-dependent process. 
To demonstrate the relevance of IR-induced and ATM-dependent upregulation of p300 
HAT activity, we examined the acetylation of one of its substrates, p53 (Ito et al., 2001; Liu et 
al., 1999; Sakaguchi et al., 1998).  Since p53 can be acetylated on multiple residues, we first 
examined the total acetylation of p53.  Extracts formed from HEK-293 cells at various times 
after IR exposure were used to immunoprecipitate p53 using anti-p53 antibody and probed with 
anti-acetyl lysine antibody (PAN-193). We found that irradiation resulted in acetylation of p53 at 
2 and 4 hr post-treatment (Figure 6, top panel). Consistent with activation of ATM after 
irradiation, we also observed the phosphorylation of p53 on serine 15 as well (Figure 6, bottom 
panel). Thus, normal response to IR exposure includes coordinated phosphorylation and 
acetylation of p53.  
When we tested the effect of caffeine and wortmannin, we detected that IR-induced p53 
acetylation was completely abrogated in cells pretreated with caffeine (Figure 7A, top panel). Of 
note, caffeine pretreatment had a quantitative effect on accumulation of Ser15-phosphorylation 
but did not completely block this irradiation-induced event (Figure 7A, bottom panel). Likewise, 
normal fibroblasts pretreated with wortmannin inhibited IR-induced acetylation (Figure 7B, top 
panel) and Ser15 phosphorylation (Figure 7B, bottom panel) of p53. Comparing p53 acetylation 
and Ser15 phosphorylation in normal (Figure 7C, lane 1-4) and A-T (Figure 7C, lane 5-8) 
fibroblast lines revealed a significant reduction in both IR-induced acetylation and 
phosphorylation of p53 in A-T cells. Taken together, the inability of ATM-deficient cells to 
upregulate p300 HAT activity and acetylate p53 in response to ionizing radiation strongly 
suggests that, in addition to phosphorylating p53, ATM directs p53 acetylation after irradiation 
by upregulating p300 HAT activity. The inhibitory effect of caffeine and wortmanin on IR-
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induced p53 phosphorylation and acetylation reinforced the requirement of ATM kinase in 
mediating these modifications. 
 
 
 
 
  
   
Figure 6: Time-course of p53 acetylation and phosphorylation in 293 cells after IR 
HEK-293 cells were exposed to 5 Gy of irradiation and harvested 2, 4, 8 h later. The 
lysates from irradiated and unirradiated cells were subjected to immunoprecipitation with 
anti-p53 antibody. Subsequently, immunocomplexes were probed with anti-acetylated 
lysine (PAN 193) or anti-phosphorylated-p53 (Ser15) antibody. The membrane was 
stained with amido black after transfer to assure equal loading in all lanes.  
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 Figure 7: p53 acetylation after IR exposure is an ATM-dependent process. 
(A) Normal (GM00730) fibroblasts were either untreated or pretreated with 5 mM of 
caffeine for 1 h and exposed to 5 Gy IR. The lysates were prepared and subjected to 
immunoprecipitation with anti-p53 antibody and subsequently stained for acetylated or 
phosphorylated (Ser15) p53 abundance. (B) Normal cells treated with wortmannin (and 
untreated cells were subjected to IR and the harvested cells were immunoprecipitated 
with anti-p53 antibody. Consequently, the immune-complexes were probed with anti-
acetylated lysine or anti-phosphorylated-p53 (Ser15) antibody. (C) Normal (GM00730) 
and A-T (GM02530) fibroblasts were either unirradiated or exposed to 5 Gy of IR and 
harvested at indicated time points after irradiation, immunoprecipitated with anti-p53 
antibody, and analyzed for acetylated p53 and Ser15 phosphorylated p53. 
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2.3.5 Phospho- p53 is a preferred target for p300. 
IR exposure triggers phosphorylation of p53 on a number of residues and these events 
results in its stabilization and accumulation (Banin et al., 1998; Canman et al., 1998; Hirao et al., 
2000). Moreover, we have documented that irradiation leads to both phosphorylation and 
acetylation of p53 (Figure 6); thus, we investigated a potential role for p53 phosphorylation in 
directing p53 acetylation. We followed a time course of phosphorylation and acetylation of p53 
in response to exposure to IR in HEK-293 cells (Figure 8A). We observed no detectable p53 
acetylation 30 minutes after irradiation, modest acetylation 1 hour after irradiation and optimal 
acetylation 2, 4 and 8 hour after IR (Figure 8A, top panel). However, when we probed these 
extracts with anti-phospho-Ser15 p53 antibody (Figure 8A, bottom panel), we observed maximal 
Ser15 phosphorylation within 30 minutes after irradiation. This indicated that Ser15 
phosphorylation precedes p53 acetylation in response to IR.  
Next, we examined the co-operation of phosphorylation in the acetylation of p53 using 
both in vivo and in vitro approaches. We used recombinant p53 (GST-p53) as substrate and 
preformed in vitro kinase assay using immunoprecipitated ATM from irradiated cells. The GST-
p53 beads were then subjected to in vitro acetylation using immunoprecipitated p300 from 
irradiated cells. Acetylation of GST-p53 was observed to be negligible in absence (Figure 8B, 
top panel, lane 1 & 3), but increased several folds in presence of phosphorylation (Figure 8B, top 
panel, lane 2 & 4).  
We also used tetracycline-inducible (Tet-off) cell line (LNZ-308) to determine the 
kinetics of phosphorylation and acetylation of p53 in response to IR. When p53 was artificially 
induced in LNZ-308 by removing tetracycline (Figure 9A, top panel), there was no 
corresponding increase in either IR-induced phosphorylation or acetylation (Figure 9A, middle & 
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bottom panel). However, in response to γ-irradiation, LNZ-308 cells exhibited not only an 
induction of total p53 but also concomitant phosphorylation on serine 15 and associated p53 
acetylation (Figure 9B). These results suggested an increase in p53 levels can’t induce 
phosphorylation or acetylation without increased kinase and acetyltransferase activity. Taken 
together, these results clearly indicate that phosphorylation renders p53 a preferred target for 
p300-dependent acetylation in response to ionizing radiation. 
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Figure 8: Phosphorylated p53 is a preferred substrate for acetylation.  
(A) Time-course for HEK-293 cells after exposure to γ-radiation. HEK-293 cells were 
exposed to 5 Gy of IR and cell lysates prepared 0.5, 1, 2, 4 and 8 hours post-irradiation. 
These lysates from unirradiated cells were analyzed for acetylated p53 and phospho-
Ser15-specific p53. (B) In vitro phosphorylation of GST-p53 followed by in vitro 
acetylation. Anti-ATM immunoprecipitates prepared from IR-treated or untreated cells 
were used to phosphorylate recombinant GST-p53 fusion protein in vitro. Subsequently, 
the product was re-purified and used as substrate in in vitro acetylation assays using 
immunoprecipitated p300. Total p53 was analyzed in the reactions to assure equivalent 
substrate in all reaction.  
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 Figure 9: Increased p53 level is unabl e to upregulate p53 acetyla tion and 
phosphorylation without IR. 
(A) p53 was synthetically induced in p53-defecient LNZ-308 glioma cells in absence of 
any exposure to γ-radiation by removing tetracycline from the cell medium. Harvested at 
1, 2, and 4 days after drug removal, cell lysates were immunoprecipitated with total p53 
(DO-1) antibody and examined for total, phosphorylated-p53 and acetylated-p53. (B) p53 
was induced in LNZ-308 cells by subjecting them to 5 Gy of irradiation. Later the cells 
were harvested at 2, 4 or 8 hr post-IR, the lysates were immunoprecipitated with p53 
(DO-1) antibody and analyzed for total, phosphorylated- and acetylated-p53. 
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2.3.6 IR-induced acetylation of p53 is regulated by two converse mechanisms. 
To confirm the role of p300 HAT activity in regulating p53 acetylation, cells were treated 
with p300 HAT activity inhibitor, Lys-CoA, at different concentrations (0, 1, 10 mM) and p53 
acetylation was assessed. At 1 mM concentration, Lys-CoA treatment decreased p53 acetylation 
by 50% and at 10 mM, a complete inhibition was observed (Figure 10A). Studies of Kim et al. 
(Kim et al., 1999a) showed that ATM interacts with the histone deacetylase HDAC1 and the 
extent of this association is increased after exposure to ionizing radiation suggesting a possible 
contribution of ATM-mediated inhibition of HDAC1 activity to p53 acetylation. To evaluate the 
contribution of HDAC1 in driving p53 acetylation after IR exposure, we treated HEK-293 cells 
with increasing doses of HDAC 1 inhibitor, Trichostatin A (TSA), and examined IR-induced p53 
acetylation. As show in Figure 10B (top panel), TSA treatment raised the basal level of p53 
acetylation slightly in unirradiated cells. Further, at 4 and 8 hr post-IR, enhanced acetylation of 
p53 was observed (Figure 10B & 10C). Neither TSA nor Lys-CoA impacted p53 
phosphorylation on S15 (Figure 10B, bottom panel). These results suggest that, p53 acetylation, 
in response to IR exposure, is simultaneously regulated by activating p300 HAT and conversely 
HDAC1 inhibition.   
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Figure 10: Effect of Lys-CoA and TSA on p53 phosphorylation and acetylation.   
(A) Normal fibroblasts (GM 00730) pretreated with Lys-CoA at 1, 10 or 100 mM 
concentration were irradiated with 5 Gy of γ-radiation. The lysates were formed and were 
immunoprecipitated with p53 (DO-1) antibody and analyzed for acetylation or 
phosphorylation. (B) Normal fibroblasts (GM00730) pretreated either with Lys-CoA (100 
mM) or Trichostatin A (1 µM) or mock-treated were irradiated with 5 Gy of IR. Lysates 
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were formed and were immunoprecipitated with p53 (DO-1) antibody and analyzed for 
the presence of acetylated or phosphorylated p53. (C) Fold increase or decrease in 
acetylated level of p53 in Lys-CoA or TSA pretreated normal human fibroblasts 
subjected to 5 Gy of IR as compared to mock-treated cells was determined.  
2.3.7 Relocalization of ING2 following γ-irradiation 
ATM exerts its function as a signal transducer. Therefore, it is possible that ATM 
mediates p300 HAT activity through intermediate proteins. Harris et al. reported that ING2 
promotes acetylation of p53 on lysine 320 after DNA damage caused by etoposide and 
neocarzinostatin (Nagashima et al., 2001a). Thus, we examined the involvement of ING2 in 
p300 activation. ING2, a member of Inhibitor of Growth (ING) family, was found by homology 
search of another family member p33ING1b (Shimada et al., 1998). ING family proteins are 
viewed as histone acetyltransferase and histone deacetylase co-factors, and participate in  
regulating transcription, cell cycle arrest, DNA repair and apoptosis (Campos et al., 2004). Since 
ING2 was reported to enhance the acetylation of p53 after DNA damage, we hypothesized that 
ING2 increases the HAT activity of p300 after Ionizing Radiation (IR).  
To that end, we examined intracellular ING2 protein levels after IR. Immunoblotting 
showed very little increase in ING2 protein level following irradiation (data not shown). Thus, 
subcellular distribution of ING2 in the cell was examined by immunofluorescence. Staining of 
cells with rat monoclonal anti-ING2 antibody revealed periplasmic nuclear staining in mock-
treated control cells (Figure 11). However, within 4 hr after 5 Gy γ-radiation treatment we 
observed bright signaling both in the cytoplasm and nucleus.  Merged images of DNA (DAPI 
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staining) and ING2 stained cells confirmed the relocalization of ING2 in response to IR 
exposure.  
Taken together, the results demonstrated that although cellular levels of ING2 increased 
modestly, a clear translocation of ING2 from periplasm to cytoplasm and nucleus was observed 
following exposure to IR.  
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Figure 11: Relocalization of ING2 after IR 
 HeLa cells were grown on pre-sterilized glass coverslips and treated with DMSO (mock) 
or γ-irradiation 5 Gy. Four hours after treatment, cells were fixed, and stained with ING2 
antibody (rabbit, red) for 1 hr at 37oC.  Cells were subsequently stained with Alexa Fluor 
555 conjugated goat anti-rabbit IgG secondary antibody. DNA was counterstained with 
DAPI (blue).  Photomicrographs were recorded using a Nikon fluorescence microscope 
(TE S2000) equipped with CCD camera. Shown also is the merged image. 
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 2.3.8 ING2 is required for the IR-induced p53 acetylation 
To examine the involvement of ING2 in p300 HAT activation induced by IR, we 
suppressed ING2 expression in HCT116 cells using shRNA approaches as described in methods. 
As control, luciferase shRNA was used.  Immunoblotting of the lysates prepared from control 
Luc- and ING2-knocked down cells confirmed suppression of ING2 protein expression in 
shING2 cells (Figure 12A).  Subsequently, shING2 and control shLuc cells were exposed to 5 
Gy of IR and p53 acetylation was assessed at 2, 4 and 8 hours post-treatment by 
immunoprecipitation.  As anticipated, IR exposure induced a time-dependent increase in p53 
acetylation in Luciferase knocked down cells.  At each of the time point examined, ING2-
knocked down cells showed low levels of p53 acetylation compared to shLuc cells (Figure 12B). 
Since p53 is the substrate of p300, p53 acetylation level can be used to measure p300 HAT 
activity. These results show decreased p53 acetylation following suppression of ING2 
expression. suggesting a requirement for ING2 in p300 HAT activation in response to γ-
radiation.  
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 Figure 12: ING2 is indispensable for p53 acetylation induced by IR 
(A) Lysates formed from shLuc and shING2 cells were subjected to immunoblotting with 
rat monoclonal anti-ING2 antibody. Anti-β-tubulin immunoblotting shows equal protein 
loading. (B) Control shLuc and ING2 knocked down shING2 cells were exposed to 5 Gy 
IR. Cell lysates were prepared at 0, 2, 4 and 8 hours post-irradiation and subjected to 
immunoprecipitation with anti-p53 antibody and subsequently stained for acetylated or 
total p53 abundance. 
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 2.3.9 p300 interacts with ING2 in an ATM-dependent manner. 
ING2 activates p53 by enhancing its p300-dependent acetylation in replicative 
senescence (Pedeux et al., 2005). In this process, ING2 functions as a scaffold protein increasing 
the association between p300 and p53.  We documented that in response to irradiation, p300 
HAT is activated and this upregulation requires ING2 function. These findings lead us to test the 
interaction between p300 and ING2 following irradiation by co-immunoprecipitation assay. 
Anti-300 immunocomplex prepared from IR-treated cells showed the presence of ING2 (Figure 
13A). The time course analysis showed optimal association at 2 hours after IR. Since ATM 
function was found to be indispensable for p300 HAT activation, we further investigated whether 
ATM is also required for the ING2 and p300 interaction. IR-induced association between ING2 
and p300 was completely abrogated in HEK-293 cells pretreated with caffeine (Figure 13B), in 
agreement with the inhibitory effect of caffeine on p300 HAT activation. Comparing the 
association in normal and A-T fibroblast lines revealed a significant reduced interaction between 
ING2 and p300 in A-T cells compared to normal cells (Figure 13C). The inability of ATM-
deficient cells to upregulate p300 HAT activity and to promote association between ING2 and 
p300 in response to ionizing radiation strongly suggests that ATM regulates p300 HAT activity 
through ING2. Perhaps, ING2 acts as an adaptor to promote interaction between ATM and p300 
consequently stimulating p300 HAT activity.  
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 Figure 13: Association between ING2 and p300 post –IR requires ATM function.  
(A) HEK-293 cells were exposed to 5 Gy of IR. Cell lysates were prepared at 0, 1, 2, 4 
and 8 hours post-irradiation and subjected to immunoprecipitation with anti-p300 
antibody and subsequently stained for ING2 association or p300 abundance. (B) HEK-
293 cells were pretreated either with caffeine or were left untreated. The cells were 
irradiated with 5 Gy of IR and the lysates prepared 0 and 2 hours after IR from these 
and untreated cells were immunoprecipitated with p300 antibody and analyzed for the 
presence of ING2 or p300 abundance. (C) SV-40 transformed isogenic fibroblast lines 
ATM-proficient YZ-5 and ATM-deficient EBS-7 were either exposed to 5 Gy of IR.  
Lysates were harvested and prepared 0 and 2 hours post-irradiation from these cells, and 
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were immunoprecipitated with p300 antibody and analyzed for the presence of ING2 or 
p300 abundance. 
2.4 DISCUSSION 
Acetylation modification has emerged as an important mechanism for activation of 
apoptosis in response to genotoxin-induced DNA damage. However, the signaling events leading 
to this modification remains unclear. In this part, we document that exposure of cells to IR 
upregulates p300 HAT activity and that IR-activated p300 acetylates p53 in an ATM-dependent 
manner. Consistent with this, treatment of cells with the ATM inhibitor, caffeine blocked p300 
HAT activation and p53 acetylation induced by IR. Moreover, IR exposed A-T cells failed to 
activate p300 HAT activity and induce p53 acetylation. Restoration of ATM expression in A-T 
cells reinstated both these responses. Examination of requirement of ATM-mediated 
phosphorylation revealed that phospho-p53 is a preferred target for activated p300. Thus, these 
findings lead to conclude that ATM regulates p53 acetylation through a dual mechanism 
involving activation of p300 HAT and enhancing p53 as a target for HAT through 
phosphorylation.   
2.4.1 p300 activation and phosphorylation 
Given that ATM activates almost all of its downstream targets through phosphorylation, a 
plausible hypothesis would be that ATM stimulates p300 HAT through direct phosphorylation.  
However, immunoblotting of p300 purified from IR-exposed cells with an antibody that 
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recognizes S/T phosphorylated ATM substrates failed to bind (data not shown). Presumably, 
p300 is not a direct target of ATM kinase. A recent study has shown that phosphorylation of 
p300 by p38 MAP kinase activates its myogenic differentiation property (Bratton et al., 2009). In 
addition, other kinases such as c-Abl and protein kinase C (PKC) has been implicated in DNA 
damage responses (Yoshida, 2007; Yoshida, 2008). Such findings raise the possibility these DSB 
responsive kinases may activate p300 through phosphorylation. The identification of p300 in 
BRCA1 complexes (Jeffy et al., 2005) that is thought to act as a scaffold for mediating 
interaction with DNA repair molecules support the possibility that p300 may join DNA damage 
surveillance complex and that this association may facilitate its phosphorylation and activation of 
the repair components.   
2.4.2 Role of ING2 in p300 HAT activation 
Irrespective of phosphorylation, we have observed that ING2, implicated in p53 
acetylation, is required for IR-induced p300 HAT activation. In support of this notion, we 
documented that suppression of ING2 expression attenuated p300 HAT activation in response to 
IR.  Moreover ING2-knocked down cells displayed attenuated IR-induced p53 acetylation. These 
results allow us to conclude that, in addition to ATM, ING2 is yet another required component in 
the IR-induced activation of p300 HAT activity. Previous studies established that ING2 is 
documented to promote acetylation through its entry into complexes containing HDAC and 
HATs, thus acts as a scaffold to facilitate their interaction with acetylation targets at the DNA 
damage site (Doyon et al., 2006; Shi et al., 2006).  Since co-immunoprecipitation assays showed 
enhanced interaction between p300 and ING2 following IR exposure, we propose that binding of 
ING2 to p300 may activate its HAT activity.   
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2.4.3 Functional Relevance of Plant Homeodomain (PHD) in ING2  
The plant homeodomain (PHD) is a relatively small motif of 60 amino acids that is 
found in >400 eukaryotic proteins, many of which are believed to be involved in the regulation 
of gene expression, including the KAP-1/TIF1 , WCRF/WSTF, Mi-2 and CBP/p300 families 
(Aasland et al., 1995). It has been suggested that this domain is involved in protein−protein 
interactions related to a possible role in chromatin-mediated regulation of gene expression 
(Jacobson and Pillus, 1999). The presence of PHD domains in both ING2 and p300 raise the 
possibility that p300 HAT activation could potentially be mediated by PHD-PHD interaction. In 
fact, the acetyl-transferase domain of p300 encompasses an analogous PHD domain (C/H2 as 
well as intervening sequence and the N-terminal part of C/H3).  Thus, interaction at region may 
allow switching the more closed configuration of p300 to an open one, resulting in accessibility 
of acetylation of critical lysine residues which may otherwise be buried inside, consequently 
leading to increased auto-acetylation and hence increasing HAT activity. An open configuration 
may also provide increased accessibility to acetyl CoA and substrate binding (Figure 14). 
Consistent with this notion, we have observed that a correlation between increased auto-
acetylation and increased HAT activity (data not shown). Of note, finer mapping of the regions 
required for HAT activity revealed that the plant homeodomain domain (PHD) of p300 which is 
originally mapped to the HAT domain of p300 (1195-1673) is shown to be dispensable for the in 
vitro acetylation activity of p300 (Bordoli et al 2001). Clearly, additional experimentations are 
required to fully elucidate the mechanism of p300 HAT activation induced by ING2 binding.  
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 Figure 14: Proposed model for p300 HAT activation by ING2. 
a) p300 maintains a closed inactive conformation in normal cells. b) Following IR, ING2 
translocates into the nucleus and binds to p300. c) ING2 binding perturbs p300 thus 
unfolding and leading to an open conformation. d) This promotes auto-acetylation and 
activation of p300. 
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2.4.4 Functional role of p300 activation induced by IR in DNA repair 
Loss of ATM is associated with radiosensitivity, a phenotype that is shared among cells 
deficient in DSB-repair (Shiloh, 2003).  The radiosensitivity phenotype displayed by p300-/- cells 
suggests that ATM-activated p300 may participate in repair of DSB breaks induced by IR.  Thus, 
one possible function of IR-activated p300 may be to promote DNA repair through acetylation of 
DNA repair proteins.  Importantly, p300 may also acetylate histones.  Histone acetylation and 
consequential weakening of its interaction with DNA may allow sliding or falling off of histone 
to expose free naked DNA for repair complex entry facilitating repair.  The recent finding that 
Ku70, a regulatory subunit of DNA-PK associates with p300 and is acetylated in an IR-
dependent manner lends support to this possible function (Jeong et al., 2007). An analogous 
scenario could also be visualized through its documented interaction with the breast cancer 
suppressor protein BRCA1 (Zhong et al., 2002), which participates in homologous 
recombination (HR)-mediated DSB repair processes. In addition to directly contributing to DNA 
repair processes, p300 may also remodel chromatin through acetylation of its downstream target, 
sucn as p53 or p73 to facilitate DNA repair processes. The p53 has been proposed to function as 
a chromatin accessibility factor in the global genome repair (GGR) responses of the nucleotide 
excision repair (NER) pathway and p53 is shown to recruit p300 to sites of NER  (Rapic-Otrin et 
al., 2002).    
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2.4.5 Functional Role of p300 activation induced by IR in apoptosis 
In addition to activating repair process, DNA damage activates a cell death response. 
Activation of apoptosis occurs during irreparable DNA damage and in a cell-type specific 
manner.  Critical components of the cell death machinery include p53, and its homolog p73. 
Interestingly, both, in addition to being phosphorylated, are also acetylated after IR and other 
DNA damaging agent treatment. Acetylation of p53 is associated with increased DNA binding 
and transcriptional activation of p53 since mutation of critical lysine (K120) residues necessary 
for acetylation sites blocks its ability to upregulate a host of pro-apoptotic genes including, 
PUMA, Bax and E2F1 (Sykes et al., 2006; Tang et al., 2006). Similarly, p73 acetylation is 
documented to corroborate with increased apoptotic activity (Costanzo et al., 2002a). In sum, a 
host of pro-apoptotic genes including p21, MDM2, Cyclin-G, GADD45, IGFBP3 (A), IGFBP3 
(B), Bax, PIGs, PERP, p53AIP1, NOXA, and the Killer/DR5α have been show to mediate most 
of the effects of p53 and p73 (Pietsch et al., 2008). Thus, DNA damage-activated p300 HAT 
may upregulate pro-apoptotic genes through acetylation and activation of p53 and p73’s 
transcription function. The impaired cell death response observed in ATM-deficient cells raises 
the possibility that ATM-activated p300 may regulate the cell death response. In support of this 
observation, we have found that inhibition of p300 activation by Lys-CoA treatment blocked IR–
induced apoptosis (data not shown).  Moreover, A-T cells showed attenuated p53 acetylation 
after IR. It will be interesting to see if p73 is also acetylated in an ATM-dependent manner in 
response to γ-irradiation. 
Together, results of our study show that p300 HAT activity is upregulated following 
genome damage and that ATM and ING2 are required for modulation of p300 HAT activity 
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towards p53. While phosphorylation of p53 by ATM facilitates its acetylation, ING2 is 
speculated to bind p300 thereby activating its HAT activity. Activated p300, in turn, promotes 
acetylation of key DNA repair and apoptotic mediator molecules through increased acetylation. 
2.5 SUMMARY 
Results of our study showed that p300 HAT activity is upregulated by γ-irradiation. The 
striking correlation between p300 activation and p53 acetylation, and the inhibition of p53 
acetylation by Lys-CoA treatment clearly show that IR-activated p300 induces p53 acetylation. 
Further, the timing of p53 acetylation and phosphorylation and the preferential acetylation of 
phosphorylated p53 by p300 indicates that irradiation-induced post-translational modification of 
p53 is sequential in nature. Suppression of ING2 impairs the p300 HAT activation induced by 
ionizing radiation. Thus, ING2 is required for p300 HAT activation. The caffeine sensitive 
nature of the p300 HAT upregulation and the ATM-dependent association between ING2 and 
p300 indicates that ATM is a critical component in p300 HAT activation. In sum, IR-induced 
upregulation of p300 HAT is ATM- and ING2-dependent process. 
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3.0  ING2 REGULATES MNNG-INDUCED APOPTOSIS THROUGH MMR/C-ABL-
DEPENDENT P73 ACETYLATION  
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3.1 INTRODUCTION 
3.1.1 Alkylating Agent: MNNG 
DNA damage response mechanisms are crucial to limiting somatic mutations, 
maintaining genomic homeostasis, and limiting cancer development (Hartwell and Kastan, 1994; 
Loeb et al., 2003). The monofunctional SN1 alkylating (methylating) agent, N-methyl-N’-nitro-
N-nitrosoguanidine (MNNG) is an extremely mutagenic, carcinogenic agent that evokes multiple 
cellular responses including DNA repair, cell cycle arrest and apoptosis (Eadie et al., 1984; Li, 
2008; Loveless, 1969; Wyatt and Pittman, 2006). Although MNNG reacts with DNA to form 
several adducts, O-6-alkyl guanine, generated by alkylation of the DNA base, is the predominant 
cytotoxic and mutagenic lesion because of its mispairing properties (Eadie et al., 1984; Loveless, 
1969). Repair of the mutagenic O6MeG lesion by direct reversal is accomplished by the enzyme, 
methylguanine-DNA methyl-transferase (MGMT) (Foote et al., 1980; Olsson and Lindahl, 
1980). Lost or diminished MGMT activity increases MNNG-induced lesion load consequently 
raising cellular sensitivity to MNNG (Bobola et al., 1995; Kalamegham et al., 1988; Tominaga 
et al., 1997).  
   
3.1.2 Mismatch Repair System 
The mismatch repair (MMR) system (Duckett et al., 1996; Griffin et al., 1994), an 
evolutionarily conserved DNA repair mechanism, chiefly responsible for resolving post-
replicative mismatches in DNA (Modrich and Lahue, 1996), also recognizes and repairs O6MeG 
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lesions.  It has been proposed that processing of O6MeG lesions by MMR during S phase gives 
rise to DNA double-strand breaks (DSBs) that finally provoke apoptosis (Meyers et al., 2001).  
In addition to its capacity as a repair mechanism, numerous observations showed that MMR 
system is required for activation of signaling in response to persistent O6MeG lesions (Stojic et 
al., 2004a).  
The precise mechanism by which MNNG induces cell death is not known; however, 
numerous observations showed that MMR critically regulates signaling events that govern cell-
cycle arrest and cell death induced by MNNG (Kim et al., 2007; Stojic et al., 2004a). MMR-
deficient cells fail to upregulate p53 and p73 in response to DNA damage (Li, 2008).  Although 
MNNG induces p53, its requirement in cell death is cell-type specific (Kim et al., 2005; Li et al., 
2008). For example, lymphoblastoid cells expressing either a mutant form or ablated 
complement of p53 displayed heightened resistance to this alkylator. In p53 mutated gliomas, the 
same DNA lesion triggers the mitochondrial apoptotic pathway (Roos et al., 2007).  O6MeG-
triggered apoptosis also requires Fas/CD95/Apo-1 receptor activation (Kaina et al., 2007). A 
recent study showed that MMR-dependent intrinsic apoptosis is stimulated by hMLH1/c-
Abl/p73α/GADD45α retrograde signaling (Li et al., 2008). MNNG exposure also activates the 
PI-3 kinase, ATM (Adamson et al., 2002) and ATM deficiency increased MNNG sensitivity 
(Adamson et al., 2005). Activation of MAPK signaling, induced by MNNG, is shown to require 
MLH1, c-Abl and ATM (Kim et al., 2007). Moreover, they display defective activation of the 
kinases Chk1 and Chk2 (Brown et al., 2003; Stojic et al., 2004b; Wang and Qin, 2003) and 
dysregulation of these kinases in response to MNNG results in defective G2 arrest in MMR-
deficient cells (Adamson et al., 2005).  All these observations implicate MMR proteins in a 
signaling cascade that leads from DNA damage to cell cycle arrest and/or apoptosis.  The 
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inability of MMR-deficient cells to activate cell cycle arrest and cell death in response to MNNG 
and related drugs (Goldmacher et al., 1986; Kat et al., 1993; Koi et al., 1994b; Meikrantz et al., 
1998) has been termed alkylation-tolerance (Branch et al., 1993). 
 
3.1.3 Summary 
Agents, inducing O6-methylguanine (O6MeG) in DNA, such as N-methyl-N'-nitro-N-
nitrosoguanidine (MNNG) are cytotoxic and a deficiency in mismatch repair (MMR) results in 
lack of sensitivity to this genotoxin (termed alkylation tolerance). A number of DNA damage 
response proteins including c-Abl, p53 and p73 are activated by MNNG in a MMR-dependent 
manner, and several also require ATM/ATR kinase activity. Here, we show that ING2, a member 
of the inhibitor of growth (ING) family proteins is upregulated in MNNG-treated cells.  We 
further observed that ING2 regulates the cell death response induced by this alkylator through a 
mechanism involving acetylation and stabilization of p73. Induction/acetylation of p53, in 
response to MNNG, however, proceeds in an ING2-independent manner.  Inhibition of c-Abl by 
STI571 treatment blocked ING2 upregulation and p73 acetylation induced by MNNG. Similarly, 
MLH1- suppressed or mutated cells displayed defective ING2 upregulation and p73 acetylation 
in response to MNNG.  Taken together, these results indicate that MLH1- and c-Abl-dependent 
upregulation of ING2 activates the cell death response to MNNG through p73 acetylation. The 
results further suggest that inactivation of ING2>p73 signaling pathway may contribute to 
alkylation tolerance observed in MMR-deficient colorectal cancer cells.  
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3.2 MATERIALS AND METHODS 
3.2.1 Materials 
MNNG and Caffeine were obtained from Sigma-Aldrich (St. Louis, MO).  STI 571 
[Imatinib (Gleevec)] was a gift from Novartis (Basel, Switzerland). Antibodies specific for p53 
(DO-1), Caspase-3 and β-tubulin were obtained from Cell Signaling (Danvers, MA).  Antibodies 
specific for p73α and PARP-1 were obtained from Santa Cruz Biotechnology (Santa Cruz, CA).  
Antibodies specific for caspase 9, acetyl-p53 (K373/K382) and acetyl-lysine were obtained from 
Upstate Biotechnology (Lake Placid, NY). HRP-conjugated secondary antibodies were 
purchased from Novus Biologicals (Littleton, CO).  
3.2.2 Cell lines 
HeLa, HEK-293, U2OS and HCT116 were cultured in Dulbecco's modified Eagle's 
medium (DMEM) supplemented with 10% fetal bovine serum (FBS). HCT116+ch2 (H2) is an 
MLH-deficient derivative of HCT116 that has a portion of human chromosome 2 introduced by 
microcell fusion. The MMR-proficient colorectal tumor line HCT116+ch3 (H3) was created by 
the stable transfer of a portion of human chromosome 3, bearing a wild-type copy of the hMLH1 
gene, into MLH1-deficient line HCT116 (Koi et al., 1994a).  HCT116+ch2 and HCT116+ch3 
cells were maintained in DMEM containing 10% FBS supplemented with 400 μg/ml of geneticin 
(G418) as described (Koi et al., 1994a).  All Cells were grown at 37oC in a humidified 5% CO2 
incubator. 
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3.2.3 RNA interference 
Overlapping synthetic oligonucleotides corresponding to sequences specific for the 
human ING2 (5’– AGAGAGCACTAATTAATAG -3’), p53 (5’- 
GACTCCAGTGGTAATCTAC -3’), p73α (5’- CGGACTGGAAATTGTCAATATT -3’) and 
MLH1 (5’-GGTTCACTACTAGTAAACTG-3’) transcripts were hybridized and cloned into 
pSIREN-RETRO-Q (Clontech, La Jolla, CA).  The recombinant pSiren plasmid was co-
transfected with pCL-ampho plasmid encoding the packaging viral DNA into the packaging cell 
line, 293T (Clontech) using Lipofectamine 2000 (Invitrogen, Carlsbad, CA).  The supernatant 
containing the viral DNA was collected, filtered and used to infect HCT116+ch3 cells with 
polybrene-supplemented medium.  Cells were selected by incubation with puromycin (1 μg/ml) 
for 4 days and downregulation of target gene expression was confirmed by immunoblotting. 
3.2.4 Immunoblotting 
Immunoblotting will be performed as described in 2.2.5. Cells will be treated with 
indicated drugs. Treated cells, as well as untreated ones, will be harvested and extracts will be 
made for immunoblotting. The membrane will be probed with indicated antibody. 
3.2.5 Immunoprecipitation 
Briefly, ~1x106 cells were lysed in 500 μl of 1X lysis buffer (20 mM Tris-HCl, pH7.5 / 
150 mM NaCl / 5 mM EDTA / 0.5% NP40 / 1 mM NaF / 1 mM DTT / 1 mM Na-vanadate) and 
clarified by centrifugation. Lysates were adjusted for equal protein content and then incubated 
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with 5μl of antibody overnight at 4oC on a rocking platform. 25 μl of 50/50 (v/v) slurry of 
protein A-Sepharose beads (American Pharmacia Biotech) in PBS were added and incubation 
continued for another 2 hours. Immune-complexes were collected by centrifugation, washed 
three times in 1X lysis buffer containing 300 mM NaCl, once with 1X lysis buffer, and 
subsequently analyzed by SDS-PAGE and immunoblotting. 
3.2.6 Transfection 
Cells will be cultured into 24-well plate, with each well plated with 5x105 cells, and kept 
in 37oC incubator for 24 hours. Cells will be transfected with constructed plasmids or with empty 
vector. DNA for transfection will be diluted in 50 μl Opti-MEM I medium before Lipofectamine 
2000 (Invitrogen CA) is added and mixed. After being incubated for 30 min, 100 μl of complex 
will be added to each well containing cells and medium. Incubate the cells at 37oC for 24 hours 
before testing transgene expression.  
3.2.7 Flow cytometry 
Mock- (DMSO) and MNNG-treated cells were washed twice with 1X PBS, fixed by 
treatment with ice-cold 70% ethanol for 30 min on ice and stored at 4° C prior to analysis.  For 
staining, cells were incubated in PBS containing 1 mg/ml RNase A, 40 µg/ml propidium iodide 
(Sigma-Aldrich) for 30 min in the dark at 37° C and then analyzed by flow cytometry. For each 
sample, more than 3 x 104 cells were counted, and the cells with a lower DNA content (sub-G1) 
than those of the G0/G1 phase were referred to as apoptotic cells. DNA histograms were analyzed 
using ModFit (Verity Software House, Topsham, ME) software. All flow cytometry experiments 
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were performed in triplicate. The paired Student's t test was used to determine the statistical 
significance. StatView software (Abacus Concepts, Berkeley, CA) was used. A P value of less 
than 0.05 represented a statistically significant difference between the values of two group 
means. 
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 3.3 RESULTS 
3.3.1 Dose- and time-dependent Induction of ING2 in response to MNNG treatment 
ING2, a member of the inhibitor of growth (ING) family has been implicated in cellular 
responses induced by genotoxic agents such as etoposide and neocarzinostatin (Nagashima et al., 
2001b). To determine its role in alkylator-induced responses, we monitored intracellular ING2 
protein levels after treatment with MNNG.  Immunoblotting of the lysates formed at 0, 3, 6, 12 
and 24 h after treatment with MNNG (10 μM) showed a time-dependent increase in ING2 
protein level with optimal induction at 6 h post-treatment (Figure 15A, top panel). MNNG-
treated U2OS and HEK293 cells also showed similar increases in ING2 protein after treatment 
with MNNG (middle and bottom panels). ING2 induction by MNNG is also dose-dependent as 
exposure to increasing concentrations of MNNG (5, 10, 25 and 50 μM) caused a proportionate 
increase in ING2 protein levels (~1.4, 2.3, 4.1, and 4.5-fold ING2 increase; Figure 15B). When 
the induction was assessed in the presence of methyl-guanine methyl transferase (MGMT) 
inhibitor, O6-benzylguanine (BG) that increases O6-methyl lesions in DNA, the level of ING2 
increased further compared to MNNG alone treatment (Figure 15C). Thus, we conclude that 
alkylator-induced DNA damage signals ING2 protein upregulation.   
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Figure 15: MNNG treatment induces ING2 in a time- and dose-dependent manner.  
(A) HeLa, U2OS and 293 cells were exposed to 10 µM MNNG and lysates were formed 
at 0, 3, 6 and 12 and 24 h post-treatment.  Lysates were resolved on a 10% SDS-PAGE 
electrophoresis, transferred onto Immobilon-P and subjected to immunoblotting with rat 
monoclonal anti-ING2 antibody.  Equal protein loading was confirmed by anti-β-tubulin 
antibody.  (B) Dose-dependent induction of ING2 in HeLa cells.  (C) MNNG-induced 
ING2 upregulation in HeLa cells with the presence and absence of MGMT inhibitor, O6-
benzylguanine (10 µM).   
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 3.3.2 ING2 is required for MNNG-induced cell death 
To examine the involvement of ING2 in cell cycle arrest/cell death responses induced by 
MNNG, we suppressed ING2 expression in human colorectal cancer cells (HCT116+Ch3;H3) 
using shRNA approaches as described in methods. As control, luciferase shRNA was used.  
Immunoblotting of the lysates prepared from mock- and MNNG-treated knocked down cells 
confirmed suppression of ING2 protein expression in shING2 cells (Figure 16A).  Subsequently, 
shING2 and control shLuc cells were exposed to MNNG (10 µM) and % apoptotic cell 
population containing sub-G1 DNA content  was assessed at 12, 24, 48 and 72 h post-treatment 
by flow cytometry.  Result showed low levels of cell death in both Luc and ING2-knocked down 
cells at 12 and 24 h after treatment (Figure 16B).  However, at 48 and 72 h after MNNG 
treatment, shING2 cells showed reduced cell death compared to shLuc cells.  Specifically, at 72 
h after MNNG, shING2 cells showed ~2 fold reduced cell d eath than shLuc (31.8% sub-G1 in 
shING2 and ~54.8% sub-G1 in shLuc, respectively).  
Immunoblotting of the lysates with anti-caspase-3 and caspase-9 antibodies showed 
reduced cleavage in MNNG-treated shING2 cells compared to similarly-treated shLuc cells 
(Figure 16C), consistent with  attenuated cell death following suppression of ING2.  Conversely, 
shLuc and shING2 cells showed comparable G2/M population at 24 and 48 h after MNNG 
(Figure 16D).  Taken together, these results demonstrate a requirement for ING2 in the cell death 
response but not for G2/M arrest induced by MNNG. 
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Figure 16: ING2 is required for MNNG-induced cell death. 
(A) Human colorectal cancer cells (HCT116+Ch3;H3) knocked down for Luciferase 
(shLuc) or ING2 (shING2) were mock-treated or exposed to MNNG (10 µM) and lysates 
were formed 4 h later. Lysates were subjected to immunoblotting with anti-ING2 
antibody.  (B) MNNG (10 µM)-treated shLuc and shING2 cells were collected at 12, 24, 
48 and 72 h post-treated, stained with propidium iodide and % apoptosis (sub-G1) was 
assessed by flow cytometry. % sub-G1 cell population obtained from at least three 
independent experiments with mean and S.D is given. (C) Cell extracts were also formed 
and subjected to immunoblotting with caspase-3, and caspase-9 antibodies. Equal protein 
content was confirmed by anti-β-tubulin antibody. (D) % G2/M cell population obtained 
from three independent experiments with mean and S.D is given. 
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3.3.3 ING2 is dispensable for p53 stabilization/acetylation induced by MNNG 
ING2-mediated apoptosis after UV irradiation requires p53 (Chin et al., 2005).  To 
determine whether ING2-mediated cell death, induced by the alkylator (MNNG) is also 
dependent on p53, we monitored p53 levels in MNNG-treated shLuc and shING2. Both 
luciferase and ING2-knocked down cells showed similar levels of p53 induction in response to 
MNNG treatment (Figure 17A, top panel).  Examination of p53 acetylation by immunoblotting 
with anti-acetyl p53 (K373/K382) antibody showed that p53 acetylation induced by MNNG also 
proceeds in an ING2-independent manner (Figure 17A, middle panel). We next compared cell 
death triggered by MNNG in cells knocked down Luc, ING2, p53 or both p53 and ING2. After 
confirming the suppression of protein expression by immunoblotting (Figure 17B), these cells 
were exposed to MNNG and cell death was assessed 72 h post-treatment. As expected, ING2-
suppressed cells showed reduced cell death compared to Luc-knocked down (Figure 17C).  
However, cells knocked down for p53 showed only a modest reduction in cell death in response 
to MNNG treatment.  Consistent with this result, MNNG-treated shp53 showed only a slight 
reduction in PARP cleavage compared to treated shLuc cells (Figure 17D; compare lanes 6-8 to 
lanes 2-4). Cells knocked down for both p53 and ING2 showed cell death attenuation similar to 
shING2 cells. Altogether, these results demonstrated that p53 plays a modest role in cell death 
induced by MNNG.   Perhaps, p53 upregulation and acetylation induced by MNNG may activate 
its repair function. 
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 Figure 17: ING2 is dispensable for MNNG-induced p53 stabilization. 
(A) Lysates formed from mock- and MNNG (10 μM)-treated shLuc and shING2 cells 
were subjected to immunoblotting with mouse monoclonal anti-p53 (DO-1) and anti-
acetyl p53 (K372/373) antibody. Anti-β-tubulin immunoblotting shows equal protein 
loading. (B) shLuc, shp53, shING2 and shING2/p53 cells were exposed to MNNG (10 
µM) and collected at 0 and 72 h post-treatment.  Cells were stained with propidium 
iodide and % apoptosis (sub-G1) cells were determined by flow cytometry.  Experiment 
was repeated three times and the mean with S.D is given. (C) Lysates formed from 
knocked down cells shown in panel B were subjected to immunoblotting with anti-ING2, 
p53 (DO-1) and tubulin antibody. (D) Lysates formed from untreated and MNNG-treated 
shLuc, shING2, shp53 and shING2/p53 cells were subjected to immunoblotting with anti-
PARP antibody. Anti-β-tubulin immunoblotting shows equal protein loading.  
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3.3.4 ING2 regulates p73 induction/acetylation in response to MNNG 
A recent study implicated the p53 homologue, p73 in the cell death response induced by 
MNNG (Li et al., 2008). This prompted us to examine the requirement of ING2 in p73α 
induction/acetylation induced by the alkylator. Immunoblotting of the lysates prepared from 
MNNG-treated shLuc  and shING2 cells  with anti-p73α antibody showed modestly increased 
levels of p73α  at 6 and 12 h post-treatment (Figure 18A). p73α levels in treated shING2 cells 
remained unchanged during these time points. We also examined p73α acetylation by 
immunoprecipitation followed by immunoblotting with anti-acetyl antibody.  At each of the time 
points examined, shLuc cells showed p73α acetylation after treatment whereas ING2-knocked 
down cells showed very little acetylation. These results clearly demonstrated ING2 dependency 
of MNNG-induced p73 induction and acetylation. To determine if ING2 directly regulates p73α 
acetylation, we overexpressed ING2 in 293T cells by transient transfection of ING2 cDNA and 
then examined p73α acetylation. As shown in Figure 18B, cells transfected with ING2 cDNA 
showed increased p73α acetylation compared to vector-transfected cells (compare lane 1 and 3). 
MNNG treatment further increased the cellular levels of ING2 in ING2-transfected cells (lane 4). 
We also reasoned that, perhaps ING2 interacts with p73α to promote acetylation.  To examine 
this possibility, we performed a co-immunoprecipitation assay.  Anti-ING2 immunoprecipitates 
prepared from MNNG-treated 293 cells showed the presence of p73α (Figure 18C; top panel; 
lane 2). Reprobing of the membrane with anti-acetyl antibody showed that ING2-associated 
p73α is acetylated.  Untreated cells showed very little interaction and acetylation of p73α. 
Together, the results reinforced the notion that ING2 promotes p73α acetylation following 
MNNG treatment through direct binding. 
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 Figure 18: ING2 is required for MNNG-induced p73 acetylation. 
(A) ShLuc and shING2 cells were treated with MNNG (10 µM) and collected at 0, 6, 12, 
and 24 h later.  Lysates were prepared, adjusted for equal protein concentration and then 
subjected to immunoblotting with anti-p73α antibody.  An aliquot of the lysate was used 
to immunoprecipitate p73α using anti-p73α antibody.  The immune-complexes were then 
resolved on 8% SDS-PAGE, transferred onto Immobilon-P and immunoblotted with 
polyclonal anti-acetyl antibody.   Equal protein loading was confirmed by anti-β-tubulin 
immunoblotting of the lysates.  (B) 293 cells transfected with vector or ING2 cDNA and 
then either mock-treated or exposed to MNNG (10 µM).  At 4 h post-MNNG, lysates 
were prepared and used for assessment of p73α acetylation by immunoprecipitation 
followed by immunoblotting as described in panel A.  (C) Co-immunoprecipitation 
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assay. 293 cells were exposed to MNNG (10 µM) and lysates were prepared at 0 and 12 h 
after were subjected to immunoprecipitation with anti-ING2 antibody.  The immune 
complex was resolved on 4-12% SDS-PAGE and the proteins were transferred onto 
Immobilon-P.  The membrane was probed with anti-ING2 and anti-73α antibody.  The 
membrane was stripped and then re-probed with anti-acetyl antibody.  
 
3.3.5 p73 is required for MNNG-induced cell death. 
To evaluate the functional significance of ING2-dependent p73α induction/acetylation 
induced by MNNG, we compared cell death induced by this alkylator in cells suppressed either 
for ING2 or p73α or both (Figure 19A).  As expected, cell suppressed for ING2 showed reduced 
cell death compared to control luciferase knocked down cells (Figure 19B).  Surprisingly, cells 
suppressed for p73α showed much reduced cell death (~18.7% sub-G1) than shING2 cells 
(~31.8% sub-G1). Corroborating well this result, decreased Caspase-3 cleavage was observed in 
the MNNG-treated shp73α cells than similarly-treated shING2 cells (Figure 19C). The 
comparatively reduced cell death observed in shp73α cells than shING2 cells suggests a 
prominent role for p73α in MNNG-induced apoptosis.  Cells knocked down for both shING2 and 
p73α cells showed cell death (~17.4% sub-G1) comparable to p73α knocked down cells (~18.7% 
cell death).  Caspase-3 cleavage was also comparable in shING2/p73 and shp73α cells (Figure 
19C).  Clearly, although modification of p73α induced by MNNG is dependent on ING2, the 
comparatively reduced cell death observed in shp73 cells than in shING2 cells suggests an 
ING2-independent role for p73α in MNNG-induced cell death. 
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Figure 19: MNNG-induced cell death in cells knocked down for ING2, p73 or both. 
(A) Lysates prepared from shLuc, shING2, shp73 and shING2/p73 cells were subjected 
to immunoblotting against p73α, ING2 and tubulin antibody.  (B) ShLuc, shLuc/p73, 
shING2 and shING2/p73 cells were mock-treated or exposed to MNNG (10 µM) and 
collected at 72 h post-treatment.  Cells were stained with propidium iodide and % sub-G1 
cell population was assessed by flow cytometry.  Mean of three experiments with S.D is 
given. (C) Lysates formed from mock- and MNNG-treated cells described in panel B 
were subjected to immunoblotting with anti-caspase-3 and anti-β-tubulin antibody. 
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3.3.6 C-Abl-dependent acetylation of p73 activates the cell death response to MNNG 
The proto-oncogene kinase, c-Abl is activated in response to MNNG treatment (Kim et 
al., 2007).  Moreover, MNNG treatment is shown to trigger a cell death response that is 
dependent on c-Abl. (Li et al., 2008).  Given this, we asked whether Abl is required for MNNG-
induced ING2 upregulation and p73 acetylation.  To that end, we pretreated H3 cells with Abl 
inhibitor STI571 and then examined ING2 induction. As shown in Figure 20A, pretreatment with 
Abl inhibitor STI571, blocked ING2 upregulation (compare lane 2 to 4).  In addition, STI571 
blocked p73α acetylation (Figure 20B; compare lane 2 to 4) induced by MNNG.  Furthermore, 
STI571 treatment blocked cell death induced by MNNG, in agreement with a recent report (Li et 
al., 2008). Clearly, c-Abl is a required component in the ING2-mediated signaling and cell death 
induced by MNNG. 
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 Figure 20: STI571 blocks MNNG-induced ING2 upregulation and p73 acetylation. 
(A) 293 cells were exposed to MNNG (10 µM) in the presence or absence of STI571 (1 
µM) and ING2 upregulation was assessed by immunoblotting.  (B)  Lysates were also 
used for determination of p73 acetylation status by immunoprecipitation followed by 
immunoblotting as described in Method. (C) shLuc and shING2 were exposed to MNNG 
(10 µM) in the presence of STI571 (1 µM) and % cell death was assessed 72 h post-
MNNG by flow cytometry. Mean of three independent experiments with S.D is given. 
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3.3.7 MMR dependency of ING2/ p73 induction by MNNG 
Since c-Abl activation by MNNG requires MMR function, we assessed its requirement in 
ING2/p73α signaling induced by MNNG. To that end, we exposed MLH1-deficient (HCT116) 
and its isogenic-proficient (HCT116/MLH1+) counterpart to MNNG (10 μM) and at varying 
time-points lysates were prepared and were subjected to immunoblotting with anti-ING2 
antibody. As shown in Figure 21A, induction of ING2 was observed in MLH1-positive 
(HCT116/MLH1+) cells (Figure 21A; top panel, lanes 6-8).  MLH1-deficient counterpart, on the 
other hand, showed very little ING2 induction (lanes 2-4). Assessment of p73α 
induction/acetylation by immunoprecipitation followed by immunoblotting with anti-acetyl 
(PAN) antibody showed MMR dependency of p73α acetylation (Figure 21A). Similarly, cells 
knocked down for MLH1 failed to display ING2 induction and p73α induction/acetylation in 
response to MNNG treatment (Figure 21B). Together, these results demonstrated that, in 
addition to c-Abl, the function of MLH1 is required for activation of ING2>p73α signaling 
triggered by MNNG. 
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 Figure 21: MMR function is requ ired for MNNG-induced ING2 induction and p73  
acetylation. 
(A) MLH1-deficient (HCT116) and –proficient (HCT116/MLH1+) cells were exposed to 
MNNG (10 µM) and lysates were formed at 0, 3, 6 and 12 h post-MNNG.  Lysates were 
adjusted for equal protein concentration and subjected to immunoblotting with anti-ING2 
antibody. The membrane was re-probed with anti-73α antibody.  An aliquot of the lysates 
was also subjected to immunoprecipitation with anti-p73α antibody and the immune-
complex was analyzed for acetylation status by immunoprecipitation followed by 
immunoblotting with anti-acetyl antibody.  Anti-β-tubulin immunoblotting shows equal 
protein loading. (B) H3 cells knocked down for luciferase (shLuc) or MLH1 (shMLH1) 
were MNNG treated and at 3, 6 and 12 h post-treatment were subjected to 
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immunoblotting with anti-ING2, p73α and anti-tubulin antibody. p73α acetylation was 
assessed as described in panel A.  
3.3.8 ATM/ATR independency of ING2/ p73 acetylation induction by MNNG 
In addition to responding to DNA damage inflicted by IR and UV, the PI3-kinases, ATM 
and ATR have been shown to respond to MNNG(Adamson et al., 2002). Specifically, MNNG 
treatment is shown to stimulate ATM/ATR kinase activity, consequently inducing a G2/M arrest 
response that is dependent on intact ATM/ATR function (Adamson et al., 2005; Stojic et al., 
2004a). Given this, we asked whether ATM/ATR kinases are required for activation of 
ING2>p73α signaling. For this purpose, we exposed HEK-293 cells to MNNG in the presence of 
ATM/ATR kinase inhibitor, caffeine and then assessed ING2 induction and p73α acetylation.  
Result showed comparable ING2 upregulation in the presence or absence of caffeine (Figure 
22A). We next compared normal (GM02530) and ATM-deficient human fibroblasts (GM1588A) 
for ING2 induction. Again, comparable ING2 accumulation was observed in MNNG-treated 
ATM-proficient and –deficient cells (Figure 22B). Similarly, ATM- reconstituted (YZ-5) and 
ATM-deficient (EBS) cells showed similar levels of ING2 accumulation in response to MNNG 
treatment (Figure 22C). Collectively all these results showed that the function of ATM/ATR 
kinases are dispensable for MNNG-induced ING2-upregulation. 
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Figure 22: ATM and ATR are dispensable for MNNG-induced ING2 induction. 
(A) Effect of caffeine in MNNG-induced ING2 upregulation. 293 cells were treated with 
caffeine (1 mM) for 1 h and then exposed to MNNG (10 µM). Lysates were formed at 0, 
3, 6 and 12 h post-MNNG and were subjected to immunoblotting with anti-ING2 
antibody. Anti-tubulin immunoblotting shows equal protein loading. (B) ING2 induction 
in MNNG-induced ING2 induction in ATM-deficient (GM1588A) and ATM-proficient 
(GM02350) human fibroblasts  there were  treated with 10 μM MNNG for 0, 3, 6 and 12 
h. (C) ING2 upregulation following mock- and MNNG-treatment of ATM-reconstituted 
(YZ-5) and ATM-deficient cells. 
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3.4 DISCUSSION 
   Members of the ING family have been implicated in cellular responses triggered by IR, 
UV and etoposide; however, their involvement in alkylator-induced responses is not known. The 
work outlined in this study document an ING2-mediated signaling pathway that is activated by 
SN1-methylating compound, MNNG. Activation of this pathway leads to the rapid upregulation 
of ING2 protein that in turn, promotes cell death through acetylation and activation of pro-
apoptotic function of p73α. Consistent with this, suppression of ING2 protein expression by 
shRNA attenuated p73α acetylation/stabilization and cell death induced by MNNG. Intact p53 
acetylation/stabilization induced by MNNG in ING2-knocked down cells showed ING2 
independency. The relatively modest effect of p53 suppression on MNNG-induced cell death 
demonstrates its dispensability in the alkylator-induced cell death. On the other hand, the greater 
impact of p73α suppression on MNNG-induced cell death highlights the significance of this p53 
homologue in eliciting cell death response induced by this alkylator. Since MGMT inhibitor, O6-
Benzylguanine, that increases the O6MeG lesion, augments ING2 upregulation induced by 
MNNG, we further conclude that DNA damage is a signal for activation of ING2>p73α 
activation. 
3.4.1 ING2 induction and c-Abl activation 
The precise molecular signaling events leading to ING2 upregulation in response to 
MNNG treatment are unclear. However, the lack of ING2 upregulation in MNNG-treated MMR- 
and Abl kinase compromised cells identified these proteins as upstream signaling elements of 
this pathway. It is well documented that MMR-mediated recognition and processing of O6-MeG 
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lesions lead to formation of double strand breaks. Consistent with this, several DSB responsive 
molecules, including ATM and Abl are activated by MNNG in MMR-dependent manner. Since 
ING2 protein levels is upregulated by DSB-inducing agent, neocarzinostatin (Nagashima et al., 
2001b), we propose that DSBs arising during MMR-mediated processing of O6-methylguanine 
lesion could trigger ING2 upregulation (Figure 23). The role c-Abl is unclear but its activation 
by MNNG is documented (Li et al., 2008). Further, we have observed that inhibition of Abl 
kinase by STI571 treatment blocked ING2 upregulation induced by MNNG. Thus, activated Abl 
stimulates ING2 upregulation. C-Abl-mediated targeting of proteins in the ubiquitin-mediated 
proteosome pathway has also been reported (Sionov et al., 2001). Thus, it is possible that 
activated Abl prevents ING2 degradation consequently leading to its upregulation. In support of 
this, we have observed that treatment with the Ub-mediated proteosome inhibitor, MG132 raised 
intracellular levels of ING2 (data not shown). It should be noted, however, that although ING 
genes are rarely mutated their transcript levels, they are often suppressed due to promoter 
hypermethylation in many cancer cells (Gunduz et al., 2008; Gunduz et al., 2000; Nagashima et 
al., 2001b). Thus, it is possible that failure to upregulate ING2 in response to MNNG may have 
to do with the abnormally low levels transcription in these colorectal cancer cells. Conceivably, 
lack of ING2 upregulation due to promoter silencing may lead to inability of these cells to 
activate ING2-mediated signaling events.  
3.4.2 p73 and MNNG-induced apoptosis 
It is well known that acetylation activates the transcriptional function of many molecules 
including p53 and p73 (Costanzo et al., 2002b; Ivanov et al., 2007). Specifically, acetylation of 
p53 on lysine 120 is shown to stimulate its pro-apoptotic transcriptional activity (Sykes et al., 
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2006; Tang et al., 2006). Conceivably, ING2-mediated acetylation of p73α stimulates its pro-
apoptotic activity. As a component of mSin3-HDAC1 deacetylase complex, ING1 inhibits 
deacetylase activity consequently inducing p53 acetylation following upregulation during DNA 
damage (Skowyra et al., 2001). On the other hand, ING2 is shown to facilitate p300-mediated 
p53 acetylation through direct interaction with p300 involving the PHD domain (Pedeux et al., 
2005; Wang et al., 2006b). These findings allow us to propose that ING2 promotes p73α 
acetylation through direct interaction and recruitment to DNA damage responsive 
acetyltransferase, such as p300/CBP (Pedeux et al., 2005). Co-immunoprecipitation assays 
showed the presence of ING2/p73α complex in MNNG-treated cells. Perhaps, recruitment of 
ING2/p73 complex to HAT/HDAC leads to increased acetylation. Since acetylation of p73α 
correlates its modest induction, it is possible that increase in p73α protein level could contribute 
to its activation. Importantly, compared to ING2-knocked down cells, p73α-suppressed cells 
showed much reduced cell death in response to MNNG treatment. This finding underscores the 
significance of p73 and its activation by mechanisms independent of ING2 as well. Clearly, 
additional study is required to disseminate the role of ING2-mediated acetylation of p73α in 
activating the cell death response to this alkylator.     
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 Figure 23: Proposed model for MMR-dependent activation of cell death by ING2. 
a) Recognition and repair of O6 methyl-Guanine by MMR proteins results in formation of 
DSB. b) Activation of c-Abl by DSB leads to ING2 induction which in turn promotes 
acetylation/stabilization of p73α. c) Activated p73α induces cell death through 
upregulation of apoptotic genes. 
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3.5 SUMMARY 
In sum, the principal advance stemming from this investigation is the demonstration that 
a member of ING family, ING2 regulates MNNG-induced cell death through 
acetylation/stabilization of p73α. The lack of ING2>p73 signaling in MMR-compromised cells 
suggests that inactivation of this signaling event could contribute to alkylation tolerance 
observed in MMR-deficient colorectal cells.  
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4.0  SUMMARY & FUTURE DIRECTIONS 
4.1 SUMMARY 
The main objective of this thesis is to elucidate the role of ING2 in mediating cellular 
response to DNA damage. To this end, we examined the role of ING2 in regulating responses 
triggered by ionizing radiation and alkylating agent. Previous studies have implicated ING2 in 
modulating the tumor suppressor, p53 function in response to IR through increased acetylation. 
However, the mechanism leading to p53 acetylation mediated by ING2 is not known. We have 
observed that IR activates p300 HAT activity and that the function ING2 is required for this 
p300 activation. Consistent with this, suppression of ING2 expression abrogated IR-induced 
p300 HAT activation and p53 acetylation. Additionally, we observed that protein kinase Ataxia 
Telangiectasia Mutated (ATM), a key regulator of IR responses is required for ING2-dependent 
p300 HAT activation as cells deficient in ATM displayed impaired p300 HAT activation and p53 
acetylation. Restoration of ATM in A-T cells reinstated IR-induced p300 HAT activation and 
p53 acetylation after IR exposure. In vitro studies demonstrated that ING2 binds p300 in an 
ATM-dependent manner and that ING2 facilitates acetylation of p53 by IR-activated p300. 
Examination of the relationship between ATM-mediated phosphorylation and ATM-dependent 
acetylation of p53 revealed that phospho-p53 is a preferred target for p300 HAT.  In sum, results 
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of our study demonstrated the convergence of ATM, p300 and ING2 in a common signaling 
pathway that regulates p53 function through acetylation after IR in a concerted manner. 
Evaluation of the role of ING2 in alkylating agent-induced DNA damage response 
revealed that ING2 protein level is upregulated in response to MNNG treatment. We further 
observed that ING2 regulates the cell death response induced by this alkylator through a 
mechanism that is dependent on ING2-mediated acetylation and activation of p73α. The function 
of ING2, however, was found to be dispensable for induction and acetylation of p53 triggered by 
MNNG. Inhibition of c-Abl kinase activity through treatment with STI571 (Gleevac) treatment 
blocked ING2 upregulation and p73α acetylation induced by MNNG. Similarly, cells 
compromised or suppressed for MMR (MLH1) function displayed defective ING2 upregulation 
and p73α acetylation. Collectively, all these results demonstrated that MMR- and c-Abl-
dependent induction of ING2 regulates the cell death response to MNNG. Since O6-
Benzylguanine (O6-BG) increases O6-methyl lesions in DNA, the level of ING2 raises further 
with the presence of O6-BG compared to MNNG alone treatment. Thus, we conclude that 
alkylator-induced DNA damage signals ING2 protein upregulation. Identification of p73α as a 
required component in the MNNG responses established that ING2>p73α signaling event 
contributes to the cell death response induced by this alkylator. The results further suggest that 
inactivation of ING2>p73α signaling event may contribute to alkylation tolerance observed in 
MMR-deficient human colorectal cancer cells.  
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4.2 FUTURE DIRECTIONS 
4.2.1 Mapping of ATM phosphorylation site using MALDI-TOF Mass Spectrometry 
As mentioned above, a plausible explanation for ATM dependency of p300 HAT 
activation is that direct phosphorylation of p300 by ATM leads to increased HAT activity. ATM 
substrates share a common motif: X-X-X-B-(S/T)-Gln-X-X-X-X, where B can be Ala, Ile, Leu, 
Met, Asn, Pro, Ser, Thr or Val and X can be Cys, Arg, Lys or His (Kim et al., 1999b; Manke et 
al., 2003). We scanned the whole sequence of p300 and found 15 sites that comply with the 
general consensus of ATM substrate motif (Table 1).  Clearly, p300 is a potential target of 
phosphorylation by ATM. To that end, we probed p300 immunopurified with an antibody that 
detects the proteins carrying phospho-(Ser/Thr) Gln motif. However, the results showed very 
little reactivity. Because this antibody recognizes SQ/TQ motif preceded by leucine and similar 
hydrophobic amino acids but not when flanked by polarized residue like glutamine, we are 
unable to rule out the possibility that p300 is an ATM substrate. Thus, to identify modification of 
p300 by phosphorylation we propose comparative mass spectrometry analysis of p300 
immunopurified from normal and ATM-deficient cells. 
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    Table 1: Candidate ATM target sequences in p300 
Candidate Site Sequence 
S106 PGQVMASQAQQSSP 
T148 GPNQGPTQSTGMMN 
S457 PNLSTVSQIDPSSI 
T482 QVNQMPTQPQVQAK 
S772 PQTQFPSQGMNVTN 
S792 SGQAPVSQAQMSSS 
T891 TPTPPTTQLPQQVQ 
S941 QPATPLSQPAVSIE 
T991 QPEPADTQPEDISE 
T1035 QPSTSATQSSPAPG 
T1724 NQQAAATQSPGDSR 
S1873 QTPQPTSQPQPTPP 
S2047 LKPGTVSQQALQNL 
S2374 DQNSMLSQLASNPG 
S2407 DLNSNLSQSTLDIH 
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The high-accuracy matrix assisted laser desorption/ionization time-of-flight and 
nanoelectrospray ionization tandem mass spectrometric analysis offers an additional tool to 
identify potential phosphorylation site in p300. Normal and A-T cells transfected with Flag-
tagged p300 could be exposed to IR and p300 enriched by binding to Flag-beads.  The anti-p300 
immunocomplex could be resolved on SDS-PAGE gel. The ~p300 kDa band containing excised, 
phosphorylated and digested products will be subjected to mass spectrophotometric analysis.  A 
comparison of the results obtained from irradiated normal and A-T cells could potentially 
demonstrate whether p300 indeed is a direct phosphorylation target of ATM. 
An alternate approach is that if p300 is phosphorylated by ATM and this modification 
upregulated p300 HAT activity then mutation of S/T site should abolish activation. Each of the 
15 phosphorylation sites could be mutated and tested for abolishment of p300 HAT activation.    
4.2.2 Mechanism of ING2-mediated activation of p300 
The presence of PHD domains in both ING2 and p300 raises the possibility that p300 
HAT activation could potentially be mediated by PHD-PHD interaction. We had speculated that 
interaction may allow switching the more closed configuration of p300 to an open one, resulting 
in accessibility of critical residues which may otherwise be buried inside. To test this, we 
propose to delete PHD domain in p300 and ING2 and examine interaction and activation. We 
documented that suppression of ING2 expression abrogated p300 activation by IR. Future study 
could involve creation of an internally PHD deletion mutant of ING2 and then examination of 
activation of p300 activity following overexpression in 293 cells. In vitro HAT assays employing 
ΔPHD ING2 could further test the proposed mechanism of p300 activation.  
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4.2.3 Role of ING2 relocation in p300 HAT activation 
Although ING2 intracellular level is not upregulated post IR, the irradiation treatment 
affects the subcellular redistribution of ING2. Specifically, after irradiation, ING2 relocalizes 
from the cytoplasm to the nuclear suggesting a probable cytoplasmic and nuclear function. The 
requirement for ING2 re-localization in p300 HAT activation could be tested by deletion of 
nuclear localization signal and then examining its effect on p300 activation. Compared with 
control luciferase shRNA cells, ING2-knocked down cells exhibit low p53 acetylation following 
IR. Thus, acetylation of p53 in cells expressing the NLS deletion mutant of ING2 could be 
evaluated to further reinforce the notion that ING2 entry into the nucleus is a required event in 
the activation of p300 HAT activity and p53 acetylation. 
4.2.4 ING2 induction in response to MNNG 
In our study, we demonstrated the protein level of ING2 increased after MNNG 
treatment. Despite this, the molecular events leading to the induction remains obscure. This 
induction can be the result of increased transcription, enhanced translation or impaired 
degradation of ING2. The fact that treatment with the ubiquitin-mediated proteosome inhibitor 
MG132 raised the cellular levels of ING2 suggests that ING2 induction is regulated through 
inhibition of its degradation. This should be further explored. The induction of ING2 partly 
depends on functional c-Abl, whose kinase activity can be activated by MNNG (Kim et al., 
2007). The phosphorylation of ING2 by c-Abl could stabilize the protein or prevent ING2 from 
being labeled to proteasomal degradation by ubiquitin ligases. To test the hypothesis that ING2 
is phosphorylated and stabilized in response to MNNG, in vitro kinase assay of ING2 and c-Abl 
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should be conducted. If the phosphorylation sites could be mapped then mutant ING2 without 
phosphorylation sites should be introduced into the cells and ING2 induction could be examined.  
4.2.5 Role of MMR in MNNG-induced ING2 expression 
We observed that ING2 upregulation after MNNG requires MMR function. Specifically, 
we showed that functional MLH1 is indispensable. It should be noted that MMR is composed of 
6 proteins including MSH2, MSH6, PMS1, MLH1 etc. It would be interesting to see if each of 
these proteins is required for ING2 induction as this would establish the requirement of MMR 
repair complex as a whole for initiation of DNA damage signal necessary for ING2 induction. 
The recruitment of ING2 to the O6-MeG lesion also needs to be evaluated. Results of these 
studies will clarify the proposed model that methylation lesion triggers formation of MMR 
complex and this initiates the signal for ING2 upregulation.  
4.2.6 ING2,  p300 HAT activation and p73 acetylation in response to MNNG 
ING2 intracellular level is upregulated by MNNG, while IR fails to induce ING2 
expression but activates its association with histone acetyltransferase p300. There is no direct 
evidence that ING2 induction following MNNG treatment activates p300 HAT activity. But the 
acetylation of p300 acetyltransferase substrate p73 (Costanzo et al., 2002a; Mantovani et al., 
2004) suggests that p300 may be the enzyme that acetylates p73 in response to the DNA damage 
inflicted by MNNG. ING2 was capable of associating with p300 and activating p300 HAT 
activity in regulating replicative senescence (Pedeux et al., 2005). It was also reported that p300 
acetylates p73 after apoptotic dose of DNA damage agent doxorubicin (Costanzo et al., 2002a). 
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These modifications upregulate p73 transcription activity to induce pro-apoptotic gene p53AIP1. 
Similarly in our study, we have showed that p73 is acetylated in a time-dependent manner in 
response to another kind of DNA damage agent MNNG. And that acetylation correlates to the 
apoptosis following MNNG treatment. These findings prompted us to examine the interaction 
between p300 and p73 in response to MNNG and it is natural to hypothesize that MNNG-
induced ING2 increases its interactions with p300, and activates its HAT activity, which results 
in p73 acetylation. 
Unfortunately, we failed to get positive result showing direct interaction between p300 
and p73 after the treatment with MNNG, but it is still possible that p300 acetylates p73 to 
activate p73 function of mediating cell death. To examine the hypothesis, p73 acetylation 
following MNNG treatment would be measured in the cells with p300 knocked out or knocked 
down. p73 acetylation and cell death following MNNG would also be examined in the presence 
or absence of p300 HAT activity inhibitor, Lys-CoA. Study of p73 acetylation in p300 knocked 
down cells is undergoing. 
Additionally, mapping the acetylation sites of p73 is also quite worth investigating. As 
describe in 4.2.1, MALDI-TOF Mass Spectrometry could be utilized to determine the acetylation 
sites of p73. Briefly, cells will be transfected with plasmid encoding Flag-labeled p73. MNNG 
treated cells will be harvested and p73 will be immunoprecipitated from the lysates. The ~73 
kDa band will be the cut from the SDS-PAGE in which the immunocomplex is solved, and will 
be subjected to digestion and mass spectrometry analysis.  
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